|
ý
|
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
For the fiscal year ended December 31, 2017
|
|
OR
|
|
o
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
For the transition period from _____ to _____
|
|
Commission File No. 001-35517
|
Maryland
|
|
45-3148087
|
(State or other jurisdiction of
incorporation or organization)
|
|
(I.R.S. Employer
Identification No.)
|
245 Park Avenue, 42nd Floor, New York, NY 10167
(Address of principal executive offices) (Zip Code)
|
||
(212) 750-7300
(Registrant’s telephone number, including area code)
|
Title of each class
|
|
Name of each exchange on which registered
|
Common Stock, $0.01 par value per share
|
|
New York Stock Exchange
|
Large accelerated filer
o
|
|
Accelerated filer
ý
|
|
Non-accelerated filer
o
(Do not check if a smaller
reporting company)
|
|
Smaller reporting company
o
|
|
Emerging growth company
o
|
|
|
Page
|
|
|
|
|
|
|
|
|
|
•
|
our business and investment strategy;
|
•
|
our projected operating results;
|
•
|
the return or impact of current and future investments;
|
•
|
the timing of cash flows, if any, from our investments;
|
•
|
estimates relating to our ability to make distributions to our stockholders in the future;
|
•
|
defaults by borrowers in paying amounts due on outstanding indebtedness and our ability to collect all amounts due according to the contractual terms of our investments;
|
•
|
our ability to obtain and maintain financing arrangements, including securitizations;
|
•
|
market conditions and our ability to access alternative debt markets and additional debt and equity capital;
|
•
|
the amount of commercial mortgage loans requiring refinancing;
|
•
|
our expected investment capacity and available capital;
|
•
|
financing and advance rates for our target investments;
|
•
|
our expected leverage;
|
•
|
changes in interest rates, credit spreads and the market value of our investments;
|
•
|
effects of hedging instruments on our target investments;
|
•
|
rates of default or decreased recovery rates on our target investments;
|
•
|
rates of prepayments on our mortgage loans and the effect on our business of such prepayments;
|
•
|
the degree to which our hedging strategies may or may not protect us from interest rate volatility;
|
•
|
availability of investment opportunities in mortgage-related and real estate-related investments and securities;
|
•
|
the ability of Ares Commercial Real Estate Management LLC (“ACREM” or our “Manager”) to locate suitable investments for us, monitor, service and administer our investments and execute our investment strategy;
|
•
|
allocation of investment opportunities to us by our Manager;
|
•
|
our ability to successfully identify, complete and integrate any acquisitions;
|
•
|
our ability to maintain our qualification as a real estate investment trust for U.S. federal income tax purposes;
|
•
|
our ability to maintain our exemption from registration under the Investment Company Act of 1940;
|
•
|
our understanding of our competition;
|
•
|
general volatility of the securities markets in which we may invest;
|
•
|
adverse changes in the real estate, real estate capital and credit markets and the impact of a protracted decline in the liquidity of credit markets on our business;
|
•
|
changes in governmental regulations, tax law and rates, and similar matters (including interpretation thereof);
|
•
|
authoritative or policy changes from standard-setting bodies such as the Financial Accounting Standards Board, the Securities and Exchange Commission, the Internal Revenue Service, the stock exchange where we list our common stock, and other authorities that we are subject to, as well as their counterparts in any foreign jurisdictions where we might do business;
|
•
|
actions and initiatives of the U.S. Government and changes to U.S. Government policies;
|
•
|
the state of the United States, European Union and Asian economies generally or in specific geographic regions;
|
•
|
global economic trends and economic recoveries; and
|
•
|
market trends in our industry, interest rates, real estate values, the debt securities markets or the general economy.
|
•
|
Senior Mortgage Loans:
These mortgage loans are typically secured by first liens on commercial properties, including the following property types: office, multifamily, self-storage, retail, hotel, healthcare, student housing, industrial and mixed-use. Our senior mortgage loans may include construction loans. In some cases, first lien mortgages may be divided into an A-Note and a B-Note. The A-Note is typically a privately negotiated loan that is secured by a first mortgage on a commercial property or group of related properties that is senior to a B-Note secured by the same first mortgage property or group.
|
•
|
Subordinated Debt:
These loans may include structurally subordinated first mortgage loans and junior participations in first mortgage loans or participations in these types of assets. As noted above, a B-Note is typically a privately negotiated loan that is secured by a first mortgage on a commercial property or group of related properties and is subordinated to an A-Note secured by the same first mortgage property or group. The subordination of a B-Note or junior participation typically is evidenced by participations or intercreditor agreements with other holders of interests in the note. B-Notes are subject to more credit risk with respect to the underlying mortgage collateral than the corresponding A-Note.
|
•
|
Mezzanine Loans:
Like B‑Notes, these loans are also subordinated CRE loans, but are usually secured by a pledge of the borrower’s equity ownership in the entity that owns the property or by a second lien mortgage on the property. In a liquidation, these loans are generally junior to any mortgage liens on the underlying property, but senior to any preferred equity or common equity interests in the entity that owns the property. Investor rights are usually governed by intercreditor agreements.
|
•
|
Preferred Equity:
Real estate preferred equity investments are subordinate to first mortgage loans and are not collateralized by the property underlying the investment. As a holder of preferred equity, we seek to enhance our position with covenants that limit the activities of the entity in which we have an interest and protect our equity by obtaining an exclusive right to control the underlying property after an event of default, should such a default occur on our investment.
|
•
|
Other CRE Investments:
To a lesser extent, we may invest in other loans and securities, subject to maintaining our qualification as a REIT, including but not limited to commercial mortgage-backed securities, loans to real estate or hospitality companies, debtor-in-possession loans and selected other income producing equity investments, such as triple net lease equity.
|
•
|
our cash flow from operations may be insufficient to make required payments of principal of and interest on the debt or we may fail to comply with all of the other covenants contained in the debt, which is likely to result in (a) acceleration of such debt (and any other debt containing a cross-default or cross-acceleration provision) that we may be unable to repay from internal funds or to refinance on favorable terms, or at all, (b) our inability to borrow unused amounts under our financing arrangements, even if we are current in payments on borrowings under those arrangements, and/or (c) the loss of some or all of our assets to foreclosure or sale;
|
•
|
our debt may increase our vulnerability to adverse economic and industry conditions with no assurance that investment yields will increase with higher financing costs;
|
•
|
we may be required to dedicate a substantial portion of our cash flow from operations to payments on our debt, thereby reducing funds available for operations, future business opportunities, stockholder distributions or other purposes;
|
•
|
we are not able to refinance debt that matures prior to the investment it was used to finance on favorable terms, or at all; and
|
•
|
as the holder of the subordinated classes of a securitization, we may be required to absorb losses.
|
•
|
general economic or market conditions;
|
•
|
the market’s view of the quality of our assets;
|
•
|
the market’s perception of our growth potential;
|
•
|
our current and potential future earnings and cash distributions; and
|
•
|
the market price of the shares of our common stock.
|
•
|
interest rate hedging can be expensive, particularly during periods of rising and volatile interest rates;
|
•
|
available interest rate hedges may not correspond directly with the interest rate risk for which protection is sought;
|
•
|
due to a credit loss, the duration of the hedge may not match the duration of the related liability;
|
•
|
the amount of income that a REIT may earn from hedging transactions (other than hedging transactions that satisfy certain requirements of the Code or that are done through a TRS) to offset interest rate losses is limited by U.S. federal income tax provisions governing REITs;
|
•
|
the credit quality of the hedging counterparty owing money on the hedge may be downgraded to such an extent that it impairs our ability to sell or assign our side of the hedging transaction; and
|
•
|
the hedging counterparty owing money in the hedging transaction may default on its obligation to pay.
|
•
|
acts of God, including earthquakes, floods and other natural disasters, which may result in uninsured losses;
|
•
|
acts of war or terrorism, including the consequences of terrorist attacks;
|
•
|
adverse changes in national and local economic and market conditions, including local markets with a significant exposure to the energy sector, which may be affected by the current low prices of oil and related gas that could adversely affect the success of tenants in that industry;
|
•
|
changes in governmental laws and regulations (including their interpretations), fiscal policies and zoning ordinances and the related costs of compliance with laws and regulations, fiscal policies and ordinances;
|
•
|
costs of remediation and liabilities associated with environmental conditions such as indoor mold; and
|
•
|
the potential for uninsured or under-insured property losses.
|
•
|
tenant mix;
|
•
|
success of tenant businesses;
|
•
|
property management decisions;
|
•
|
property location, condition and design;
|
•
|
competition from comparable types of properties;
|
•
|
changes in laws that increase operating expenses or limit rents that may be charged;
|
•
|
changes in national, regional or local economic conditions and/or specific industry segments, including the credit and securitization markets;
|
•
|
declines in regional or local real estate values;
|
•
|
changes in local markets in which our tenants operate, including changes in oil and gas prices;
|
•
|
declines in regional or local rental or occupancy rates;
|
•
|
increases in interest rates, real estate tax rates and other operating expenses;
|
•
|
costs of remediation and liabilities associated with environmental conditions;
|
•
|
the potential for uninsured or underinsured property losses;
|
•
|
the potential for casualty or condemnation loss;
|
•
|
changes in governmental laws and regulations, including fiscal policies, zoning ordinances and environmental legislation and the related costs of compliance;
|
•
|
changes in supply (resulting from the recent growth in commercial real estate debt funds or otherwise) and demand; and
|
•
|
acts of God, terrorist attacks, social unrest and civil disturbances.
|
•
|
our actual or projected operating results, financial condition, cash flows and liquidity, or changes in business strategy or prospects;
|
•
|
actual or perceived conflicts of interest with our Manager or Ares Management and individuals, including our executives;
|
•
|
equity issuances by us, or share resales by our stockholders, or the perception that such issuances or resales may occur;
|
•
|
loss of a major funding source;
|
•
|
actual or anticipated accounting problems;
|
•
|
publication of research reports about us or the real estate industry;
|
•
|
changes in market valuations of similar companies;
|
•
|
adverse market reaction to any increased indebtedness we incur in the future;
|
•
|
additions to or departures of our Manager’s or Ares Management’s key personnel;
|
•
|
speculation in the press or investment community;
|
•
|
increases in market interest rates and widening of market credit spreads, which may lead investors to demand a higher distribution yield for our common stock and would result in increased interest expenses on our debt;
|
•
|
failure to maintain our REIT qualification or exemption from the 1940 Act;
|
•
|
price and volume fluctuations in the overall stock market from time to time;
|
•
|
general market and economic conditions, and trends including inflationary concerns, the current state of the credit and capital markets;
|
•
|
significant volatility in the market price and trading volume of securities of publicly traded REITs or other companies in our sector, which are not necessarily related to the operating performance of these companies;
|
•
|
changes in law, regulatory policies or tax guidelines, or interpretations thereof, particularly with respect to REITs;
|
•
|
changes in the value of our portfolio;
|
•
|
any shortfall in revenue or net income or any increase in losses from levels expected by investors or securities analysts;
|
•
|
operating performance of companies comparable to us;
|
•
|
short-selling pressure with respect to shares of our common stock or REITs generally;
|
•
|
uncertainty surrounding the continued strength of the U.S. economy; and
|
•
|
concerns regarding volatility in the U.S. and global financial markets.
|
•
|
our ability to make profitable investments;
|
•
|
margin calls or other expenses that reduce our cash flow;
|
•
|
defaults in our asset portfolio or decreases in the value of our portfolio; and
|
•
|
the fact that anticipated operating expense levels may not prove accurate, as actual results may vary from estimates.
|
•
|
80% of the votes entitled to be cast by holders of the then-outstanding shares of voting stock of the corporation; and
|
•
|
two-thirds of the votes entitled to be cast by holders of voting stock of the corporation, other than shares held by the interested stockholder with whom or with whose affiliate the business combination is to be effected, or held by an affiliate or associate of the interested stockholder.
|
•
|
the election or removal of directors;
|
•
|
the amendment of our charter, except that our board of directors may amend our charter without stockholder approval to:
|
•
|
change our name;
|
•
|
change the name or other designation or the par value of any class or series of stock and the aggregate par value of our stock;
|
•
|
increase or decrease the aggregate number of shares of stock that we have the authority to issue;
|
•
|
increase or decrease the number of shares of any class or series of stock that we have the authority to issue; and
|
•
|
effect certain reverse stock splits;
|
•
|
our liquidation and dissolution; and
|
•
|
our being a party to a merger, consolidation, sale or other disposition of all or substantially all of our assets or statutory share exchange.
|
|
High
|
|
Low
|
|
Cash Dividends Declared
Per Share of Common Stock |
|
||||||
Year ended December 31, 2017
|
|
|
|
|
|
|
|
|
|
|||
First quarter
|
$
|
14.17
|
|
|
$
|
12.75
|
|
|
$
|
0.27
|
|
(1)
|
Second quarter
|
$
|
14.09
|
|
|
$
|
12.90
|
|
|
$
|
0.27
|
|
(2)
|
Third quarter
|
$
|
13.39
|
|
|
$
|
12.80
|
|
|
$
|
0.27
|
|
(3)
|
Fourth quarter
|
$
|
13.65
|
|
|
$
|
12.89
|
|
|
$
|
0.27
|
|
(4)
|
|
High
|
|
Low
|
|
Cash Dividends Declared
Per Share of Common Stock |
|
||||||
Year ended December 31, 2016
|
|
|
|
|
|
|
|
|
|
|||
First quarter
|
$
|
11.83
|
|
|
$
|
9.02
|
|
|
$
|
0.26
|
|
(5)
|
Second quarter
|
$
|
12.42
|
|
|
$
|
10.97
|
|
|
$
|
0.26
|
|
(6)
|
Third quarter
|
$
|
13.00
|
|
|
$
|
12.18
|
|
|
$
|
0.26
|
|
(7)
|
Fourth quarter
|
$
|
14.27
|
|
|
$
|
12.45
|
|
|
$
|
0.26
|
|
(8)
|
(1)
|
On
March 7, 2017
, we declared a cash dividend of
$0.27
per common share of our common stock, payable on
April 17, 2017
to our common stockholders of record as of
March 31, 2017
.
|
(2)
|
On
May 2, 2017
, we declared a cash dividend of
$0.27
per share of our common stock, payable on
July 17, 2017
to our common stockholders of record as of
June 30, 2017
.
|
(3)
|
On
August 3, 2017
, we declared a cash dividend of
$0.27
per share of our common stock, payable on
October 16, 2017
to our common stockholders of record as of
September 29, 2017
.
|
(4)
|
On
November 1, 2017
, we declared a cash dividend of
$0.27
per share of our common stock, payable on
January 16, 2018
to our common stockholders of record as of
December 29, 2017
.
|
(5)
|
On
March 1, 2016
, we declared a cash dividend of
$0.26
per common share of our common stock, payable on
April 15, 2016
to our common stockholders of record as of
March 31, 2016
.
|
(6)
|
On
May 5, 2016
, we declared a cash dividend of
$0.26
per share of our common stock, payable on
July 15, 2016
to our common stockholders of record as of
June 30, 2016
.
|
(7)
|
On
August 4, 2016
, we declared a cash dividend of
$0.26
per share of our common stock, payable on
October 17, 2016
to our common stockholders of record as of
September 30, 2016
.
|
(8)
|
On
November 3, 2016
, we declared a cash dividend of
$0.26
per share of our common stock, payable on
January 17, 2017
to our common stockholders of record as of
December 30, 2016
.
|
Period
|
|
Total Number of Shares Purchased
|
|
Average Price Paid Per Share (1)
|
|
Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs
|
|
Maximum (or Approximate Dollar Value) of Shares that May Yet Be Purchased Under the Plans or Programs (in thousands)
|
||||||
January 1, 2016 through January 31, 2016
|
|
—
|
|
|
—
|
|
|
—
|
|
|
$
|
20,000
|
|
|
February 1, 2016 through February 29, 2016
|
|
—
|
|
|
—
|
|
|
—
|
|
|
$
|
30,000
|
|
|
March 1, 2016 through March 31, 2016
|
|
34,854
|
|
|
$
|
10.28
|
|
|
34,854
|
|
|
$
|
29,642
|
|
April 1, 2016 through April 30, 2016
|
|
95,062
|
|
|
$
|
11.34
|
|
|
95,062
|
|
|
$
|
28,563
|
|
May 1, 2016 through May 31, 2016
|
|
—
|
|
|
—
|
|
|
—
|
|
|
$
|
28,563
|
|
|
June 1, 2016 through June 30, 2016
|
|
—
|
|
|
—
|
|
|
—
|
|
|
$
|
28,563
|
|
|
July 1, 2016 through July 31, 2016
|
|
—
|
|
|
—
|
|
|
—
|
|
|
$
|
28,563
|
|
|
August 1, 2016 through August 31, 2016
|
|
—
|
|
|
—
|
|
|
—
|
|
|
$
|
28,563
|
|
|
September 1, 2016 through September 30, 2016
|
|
—
|
|
|
—
|
|
|
—
|
|
|
$
|
28,563
|
|
|
October 1, 2016 through October 31, 2016
|
|
—
|
|
|
—
|
|
|
—
|
|
|
$
|
28,563
|
|
|
November 1, 2016 through November 30, 2016
|
|
—
|
|
|
—
|
|
|
—
|
|
|
$
|
28,563
|
|
|
December 1, 2016 through December 31, 2016
|
|
—
|
|
|
—
|
|
|
—
|
|
|
$
|
28,563
|
|
|
January 1, 2017 through January 31, 2017
|
|
—
|
|
|
—
|
|
|
—
|
|
|
$
|
28,563
|
|
|
February 1, 2017 through February 28, 2017
|
|
—
|
|
|
—
|
|
|
—
|
|
|
$
|
28,563
|
|
|
March 1, 2017 through March 31, 2017
|
|
—
|
|
|
—
|
|
|
—
|
|
|
$
|
28,563
|
|
|
Total
|
|
129,916
|
|
|
$
|
11.06
|
|
|
129,916
|
|
|
|
(1)
|
Amount includes expenses paid.
|
SOURCE:
|
S&P Global Market Intelligence
|
NOTES:
|
Assumes $100 invested on December 31, 2012 in ACRE, the S&P 500 Index and the SNL US Finance REIT Index. Assumes all dividends are reinvested on the respective dividend payment dates without commissions.
|
|
12/31/12
|
|
12/31/13
|
|
12/31/14
|
|
12/31/15
|
|
12/31/16
|
|
12/31/17
|
||||||
ACRE
|
100.00
|
|
|
85.46
|
|
|
81.00
|
|
|
87.67
|
|
|
114.71
|
|
|
116.54
|
|
S&P 500 Index
|
100.00
|
|
|
132.39
|
|
|
150.51
|
|
|
152.59
|
|
|
170.84
|
|
|
208.14
|
|
SNL US Finance REIT Index
|
100.00
|
|
|
96.58
|
|
|
110.61
|
|
|
101.43
|
|
|
124.94
|
|
|
145.78
|
|
Plan Category
|
|
Number of
securities to be issued upon exercise of outstanding options, warrants and rights |
|
Weighted-
average exercise price of outstanding options, warrants and rights |
|
Number of
securities remaining available for future issuance under equity compensation plans (excluding securities reflected in the first column of this table)(1) |
||||
Equity compensation plans approved by stockholders
|
|
—
|
|
|
$
|
—
|
|
|
350,993
|
|
Equity compensation plans not approved by stockholders
|
|
—
|
|
|
—
|
|
|
—
|
|
|
Total
|
|
—
|
|
|
$
|
—
|
|
|
350,993
|
|
(1)
|
The securities shown in this column may be issued as restricted stock, restricted stock units and/or other equity-based awards to eligible awardees under our 2012 Equity Incentive Plan.
|
|
For the years ended December 31,
|
||||||||||||||||||
|
2017
|
|
2016
|
|
2015
|
|
2014
|
|
2013
|
||||||||||
Operating Data:
|
|
|
|
|
|
|
|
|
|
||||||||||
Net interest margin, excluding non-controlling interests held by third parties
|
$
|
46,313
|
|
|
$
|
40,568
|
|
|
$
|
40,936
|
|
|
$
|
36,551
|
|
|
$
|
22,627
|
|
Gain on sale of loans
|
—
|
|
|
—
|
|
|
—
|
|
|
680
|
|
|
—
|
|
|||||
Total expenses
|
14,970
|
|
|
14,426
|
|
|
13,671
|
|
|
14,549
|
|
|
16,475
|
|
|||||
Early extinguishment of debt costs
|
(768
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||||
Net income from continuing operations
|
30,432
|
|
|
30,451
|
|
|
36,335
|
|
|
22,749
|
|
|
12,329
|
|
|||||
Net income from operations of discontinued operations, net of income taxes
|
—
|
|
|
4,221
|
|
|
6,985
|
|
|
1,867
|
|
|
1,437
|
|
|||||
Gain on sale of discontinued operations
|
—
|
|
|
10,196
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||||
Net income attributable to common stockholders
|
$
|
30,407
|
|
|
$
|
40,336
|
|
|
$
|
34,285
|
|
|
$
|
24,396
|
|
|
$
|
13,766
|
|
Basic weighted average shares of common stock outstanding
|
28,478,237
|
|
|
28,461,853
|
|
|
28,501,897
|
|
|
28,459,309
|
|
|
18,989,500
|
|
|||||
Diluted weighted average shares of common stock outstanding
|
28,550,945
|
|
|
28,523,306
|
|
|
28,597,568
|
|
|
28,585,022
|
|
|
19,038,152
|
|
|||||
Basic earnings per common share:
|
|
|
|
|
|
|
|
|
|
||||||||||
Continuing operations
|
$
|
1.07
|
|
|
$
|
0.91
|
|
|
$
|
0.96
|
|
|
$
|
0.79
|
|
|
$
|
0.65
|
|
Discontinued operations
|
—
|
|
|
0.51
|
|
|
0.25
|
|
|
0.07
|
|
|
0.08
|
|
|||||
Net income
|
$
|
1.07
|
|
|
$
|
1.42
|
|
|
$
|
1.20
|
|
|
$
|
0.86
|
|
|
$
|
0.72
|
|
Diluted earnings per common share:
|
|
|
|
|
|
|
|
|
|
||||||||||
Continuing operations
|
$
|
1.07
|
|
|
$
|
0.91
|
|
|
$
|
0.95
|
|
|
$
|
0.79
|
|
|
$
|
0.65
|
|
Discontinued operations
|
—
|
|
|
0.51
|
|
|
0.24
|
|
|
0.07
|
|
|
0.08
|
|
|||||
Net income
|
$
|
1.07
|
|
|
$
|
1.41
|
|
|
$
|
1.20
|
|
|
$
|
0.85
|
|
|
$
|
0.72
|
|
Dividends declared per share of common stock
|
$
|
1.08
|
|
|
$
|
1.04
|
|
|
$
|
1.00
|
|
|
$
|
1.00
|
|
|
$
|
1.00
|
|
Balance Sheet Data:
|
|
|
|
|
|
|
|
|
|
||||||||||
Loans held for investment
|
$
|
1,726,283
|
|
|
$
|
1,313,937
|
|
|
$
|
1,174,391
|
|
|
$
|
1,462,584
|
|
|
$
|
958,495
|
|
Total assets
|
1,770,219
|
|
|
1,373,703
|
|
|
1,378,982
|
|
|
1,862,155
|
|
|
1,169,606
|
|
|||||
Secured funding agreements
|
957,960
|
|
|
780,713
|
|
|
522,775
|
|
|
552,799
|
|
|
264,419
|
|
|||||
Secured term loan
|
107,595
|
|
|
149,878
|
|
|
69,762
|
|
|
—
|
|
|
—
|
|
|||||
Total unsecured debt
|
—
|
|
|
—
|
|
|
—
|
|
|
67,414
|
|
|
65,893
|
|
|||||
Total securitizations debt
|
271,211
|
|
|
—
|
|
|
254,343
|
|
|
523,229
|
|
|
389,640
|
|
|||||
Total liabilities
|
1,351,049
|
|
|
944,030
|
|
|
922,494
|
|
|
1,381,269
|
|
|
763,390
|
|
|||||
Total stockholders' equity
|
419,170
|
|
|
419,029
|
|
|
409,471
|
|
|
402,954
|
|
|
406,216
|
|
|||||
Total equity
|
419,170
|
|
|
429,673
|
|
|
456,488
|
|
|
480,886
|
|
|
406,216
|
|
•
|
ACRE originated a $31.4 million senior mortgage loan on a multifamily property located in New York.
|
•
|
ACRE originated a $24.1 million senior mortgage loan on a student housing property located in Alabama.
|
•
|
ACRE originated a $24.4 million senior mortgage loan on a multifamily property located in California.
|
•
|
ACRE originated a $53.8 million senior mortgage loan on a multifamily property located in Florida.
|
•
|
ACRE amended the CNB Facility (as defined below) to extend the initial maturity date to March 11, 2018.
|
•
|
ACRE Commercial Mortgage 2017-FL3 Ltd. (the “Issuer”) and ACRE Commercial Mortgage 2017-FL3 LLC, both wholly-owned subsidiaries of ACRE, issued approximately $272.9 million principal balance
|
•
|
ACRE originated a $65.0 million senior mortgage loan on an office property located in Colorado.
|
•
|
ACRE originated a $27.1 million senior mortgage loan on a multifamily property located in California.
|
•
|
ACRE originated a $43.0 million senior mortgage loan on a student housing property located in California.
|
•
|
ACRE originated a $56.7 million senior mortgage loan on an office property located in New Jersey.
|
•
|
ACRE originated a $110.0 million senior mortgage loan on an office property located in Texas.
|
•
|
ACRE originated a $19.0 million senior mortgage loan on an office property located in Florida.
|
•
|
ACRE amended the Wells Fargo Facility (as defined below) to increase the facility’s commitment amount from $325.0 million to $500.0 million and extend the initial maturity date to December 14, 2018.
|
•
|
ACRE amended the BAML Facility (as defined below), which has a commitment amount of $125.0 million, to extend the period during which ACRE may request individual loans under the facility to May 24, 2018. In addition, the final maturity date of individual loans under the BAML Facility was extended to May 25, 2021.
|
•
|
ACRE amended the U.S. Bank Facility (as defined below) to increase the facility’s commitment amount from $125.0 million to $186.0 million and extend the initial maturity date to July 31, 2020.
|
•
|
ACRE originated an $18.1 million senior mortgage loan on a multifamily property located in California.
|
•
|
ACRE originated a $39.7 million senior mortgage loan on a student housing property located in North Carolina.
|
•
|
ACRE originated a $27.5 million senior mortgage loan on a multifamily property located in Texas.
|
•
|
ACRE amended the MetLife Facility (as defined below) to extend the initial maturity date to August 12, 2020 and decrease the interest rate on advances under the MetLife Facility to a per annum rate equal to one-month LIBOR plus a spread of 2.30%. The initial maturity date of the MetLife Facility is subject to
two
12
-month extensions, each of which may be exercised at ACRE’s option, subject to the satisfaction of certain conditions, including payment of an extension fee, which, if both were exercised, would extend the maturity date of the MetLife Facility to August 12, 2022.
|
•
|
ACRE originated a $19.2 million senior mortgage loan on a multifamily property located in Florida.
|
•
|
ACRE originated a $17.3 million senior mortgage loan on a multifamily property located in New York.
|
•
|
ACRE originated a $3.1 million mezzanine mortgage loan on an office property located in California.
|
•
|
ACRE originated an $82.0 million senior mortgage loan on an office property located in Illinois.
|
•
|
ACRE originated a $52.9 million senior mortgage loan on an industrial property located in Minnesota.
|
•
|
ACRE originated a $63.8 million senior mortgage loan on a multifamily property located in Utah.
|
•
|
ACRE originated a $30.2 million senior mortgage loan on a multifamily property located in New York.
|
•
|
ACRE originated a $40.0 million senior mortgage loan on a hotel property located in California.
|
•
|
ACRE originated a $42.7 million senior mortgage loan on a multifamily property located in Texas.
|
•
|
ACRE originated a $41.0 million senior mortgage loan on a student housing property located in Texas.
|
•
|
ACRE originated a $24.0 million senior mortgage loan on a student housing property located in Texas.
|
•
|
ACRE amended the BAML Facility (as defined below) to decrease the interest rate on advances under the facility from a per annum rate equal to one-month LIBOR plus a spread ranging from 2.25% to 2.75% depending upon the type of asset securing such advance to a per annum rate equal to one-month LIBOR plus a spread of 2.00%.
|
•
|
ACRE sold a senior mortgage loan and a B-Note mortgage loan with outstanding principal of $63.9 million and $10.0 million, respectively, which were both collateralized by an office property located in Texas, to a third party. No gain or loss was recognized on the sale.
|
•
|
ACRE voluntarily elected to repay $45.0 million of outstanding principal on the Secured Term Loan (as defined below) prior to the scheduled maturity as permitted by the contractual terms of the Secured Term Loan. In addition, ACRE amended the Secured Term Loan to, among other things, (1) decrease the interest rate on advances under the Secured Term Loan from a per annum rate equal to one-month LIBOR plus a spread of 6.00% (with a 1.00% LIBOR floor) to a per annum rate equal to one, two, three or six-month LIBOR plus a spread of 5.00% (with no LIBOR floor), (2) extend the initial maturity date to December 22,
|
•
|
the interest expense associated with our borrowings to increase, subject to any applicable ceilings;
|
•
|
the value of our mortgage loans to decline;
|
•
|
coupons on our floating rate mortgage loans to reset to higher interest rates; and
|
•
|
to the extent we enter into interest rate swap agreements as part of our hedging strategy where we pay fixed and receive floating interest rates, the value of these agreements to increase.
|
•
|
the interest expense associated with our borrowings to decrease, subject to any applicable floors;
|
•
|
the value of our mortgage loan portfolio to increase, for such mortgages with applicable floors;
|
•
|
coupons on our floating rate mortgage loans to reset to lower interest rates, subject to any applicable floors; and
|
•
|
to the extent we enter into interest rate swap agreements as part of our hedging strategy where we pay fixed and receive floating interest rates, the value of these agreements to decrease.
|
|
As of December 31, 2017
|
||||||||||||||
|
Carrying Amount (1)
|
|
Outstanding Principal (1)
|
|
Weighted Average Minimum Loan Borrowing Spread (2)
|
|
Weighted Average Unleveraged Effective Yield (3)
|
|
Weighted Average Remaining Life (Years)
|
||||||
Senior mortgage loans
|
$
|
1,674,169
|
|
|
$
|
1,684,439
|
|
|
4.8
|
%
|
|
6.2
|
%
|
|
1.9
|
Subordinated debt and preferred equity investments
|
52,114
|
|
|
52,847
|
|
|
9.5
|
%
|
|
10.8
|
%
|
|
3.4
|
||
Total loans held for investment portfolio
|
$
|
1,726,283
|
|
|
$
|
1,737,286
|
|
|
5.0
|
%
|
|
6.3
|
%
|
|
2.0
|
(1)
|
The difference between the Carrying Amount and the Outstanding Principal amount of the loans held for investment consists of unamortized purchase discount, deferred loan fees and loan origination costs.
|
(2)
|
Minimum Loan Borrowing Spread is equal to (a) for floating rate loans, the margin above the applicable index rate (e.g., LIBOR) plus floors, if any, on such applicable index rates, and (b) for fixed rate loans, the applicable interest rate.
|
(3)
|
Unleveraged Effective Yield is the compounded effective rate of return that would be earned over the life of the investment based on the contractual interest rate (adjusted for any deferred loan fees, costs, premium or discount) and assumes
no
dispositions, early prepayments or defaults. The Total Weighted Average Unleveraged Effective Yield is calculated based on the average of Unleveraged Effective Yield of all loans held by us as of
December 31, 2017
as weighted by the Outstanding Principal balance of each loan.
|
|
For the year ended December 31, 2017
|
||
Interest income from loans held for investment, excluding non-controlling interests
|
$
|
97,506
|
|
Interest income from non-controlling interest investment held by third parties
|
35
|
|
|
Interest income from loans held for investment
|
$
|
97,541
|
|
|
For the years ended December 31,
|
||||||||||
|
2017
|
|
2016
|
|
2015
|
||||||
Net interest margin
|
$
|
46,348
|
|
|
$
|
45,107
|
|
|
$
|
49,995
|
|
Total expenses
|
14,970
|
|
|
14,426
|
|
|
13,671
|
|
|||
Early extinguishment of debt costs
|
(768
|
)
|
|
—
|
|
|
—
|
|
|||
Income from continuing operations before income taxes
|
30,610
|
|
|
30,681
|
|
|
36,324
|
|
|||
Income tax expense (benefit), including excise tax
|
178
|
|
|
230
|
|
|
(11
|
)
|
|||
Net income from continuing operations
|
30,432
|
|
|
30,451
|
|
|
36,335
|
|
|||
Net income from operations of discontinued operations, net of income taxes
|
—
|
|
|
4,221
|
|
|
6,985
|
|
|||
Gain on sale of discontinued operations
|
—
|
|
|
10,196
|
|
|
—
|
|
|||
Net income attributable to ACRE
|
30,432
|
|
|
44,868
|
|
|
43,320
|
|
|||
Less: Net income attributable to non-controlling interests
|
(25
|
)
|
|
(4,532
|
)
|
|
(9,035
|
)
|
|||
Net income attributable to common stockholders
|
$
|
30,407
|
|
|
$
|
40,336
|
|
|
$
|
34,285
|
|
|
For the years ended December 31,
|
||||||||||
|
2017
|
|
2016
|
|
2015
|
||||||
Interest income from loans held for investment
|
$
|
97,541
|
|
|
$
|
81,963
|
|
|
$
|
86,337
|
|
Interest expense
|
(51,193
|
)
|
|
(36,856
|
)
|
|
(36,342
|
)
|
|||
Net interest margin
|
$
|
46,348
|
|
|
$
|
45,107
|
|
|
$
|
49,995
|
|
|
For the years ended December 31,
|
||||||||||
|
2017
|
|
2016
|
|
2015
|
||||||
Management and incentive fees to affiliate
|
$
|
6,569
|
|
|
$
|
5,956
|
|
|
$
|
5,397
|
|
Professional fees
|
1,674
|
|
|
2,228
|
|
|
2,018
|
|
|||
General and administrative expenses
|
2,828
|
|
|
2,801
|
|
|
2,830
|
|
|||
General and administrative expenses reimbursed to affiliate
|
3,899
|
|
|
3,441
|
|
|
3,426
|
|
|||
Total expenses
|
$
|
14,970
|
|
|
$
|
14,426
|
|
|
$
|
13,671
|
|
|
For the years ended December 31,
|
||||||||||
|
2017
|
|
2016
|
|
2015
|
||||||
Net income
|
$
|
30,432
|
|
|
$
|
44,868
|
|
|
$
|
43,320
|
|
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
|
840
|
|
|
(36,330
|
)
|
|
232,199
|
|
|||
Net cash provided by (used in) operating activities
|
31,272
|
|
|
8,538
|
|
|
275,519
|
|
|||
Net cash provided by (used in) investing activities
|
(405,768
|
)
|
|
(43,320
|
)
|
|
258,339
|
|
|||
Net cash provided by (used in) financing activities
|
355,569
|
|
|
73,057
|
|
|
(541,414
|
)
|
|||
Change in cash and cash equivalents
|
$
|
(18,927
|
)
|
|
$
|
38,275
|
|
|
$
|
(7,556
|
)
|
|
|
As of December 31,
|
|||||||||||||||||||||||
|
|
2017
|
|
2016
|
|
||||||||||||||||||||
|
|
Total
Commitment |
|
Outstanding Balance
|
|
Interest Rate
|
|
Maturity Date
|
|
Total
Commitment |
|
Outstanding Balance
|
|
Interest Rate
|
|
Maturity Date
|
|
||||||||
Secured Funding Agreements:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Wells Fargo Facility
|
|
$
|
500,000
|
|
(1)
|
$
|
407,853
|
|
|
LIBOR+1.75 to 2.35%
|
|
December 14, 2018
|
(1)
|
$
|
325,000
|
|
|
$
|
218,064
|
|
|
LIBOR+1.75 to 2.35%
|
|
December 14, 2017
|
(1)
|
Citibank Facility
|
|
250,000
|
|
(2)
|
175,651
|
|
|
LIBOR+2.25 to 2.50%
|
|
December 10, 2018
|
(2)
|
250,000
|
|
(2)
|
302,240
|
|
|
LIBOR+2.25 to 2.50%
|
|
December 10, 2018
|
(2)
|
||||
BAML Facility
|
|
125,000
|
|
|
78,320
|
|
|
LIBOR+2.00%
|
(3)
|
May 24, 2018
|
(3)
|
125,000
|
|
|
77,679
|
|
|
LIBOR+2.25 to 2.75%
|
|
May 25, 2017
|
(3)
|
||||
CNB Facility
|
|
50,000
|
|
|
—
|
|
|
LIBOR+3.00%
|
|
March 11, 2018
|
(4)
|
50,000
|
|
|
—
|
|
|
LIBOR+3.00%
|
|
March 11, 2017
|
(4)
|
||||
MetLife Facility
|
|
180,000
|
|
|
101,131
|
|
|
LIBOR+2.30%
|
(5)
|
August 12, 2020
|
(5)
|
180,000
|
|
|
53,130
|
|
|
LIBOR+2.35%
|
|
August 12, 2017
|
(5)
|
||||
UBS Facility
|
|
140,000
|
|
|
34,000
|
|
|
LIBOR+1.88 to 2.28%
|
(6)
|
October 21, 2018
|
|
140,000
|
|
|
71,360
|
|
|
LIBOR+1.88 to 2.28%
|
(6)
|
October 21, 2018
|
|
||||
U.S. Bank Facility
|
|
185,989
|
|
(7)
|
161,005
|
|
|
LIBOR+1.85 to 2.25%
|
|
July 31, 2020
|
(7)
|
125,000
|
|
|
58,240
|
|
|
LIBOR+2.25%
|
|
July 31, 2019
|
(7)
|
||||
Subtotal
|
|
$
|
1,430,989
|
|
|
$
|
957,960
|
|
|
|
|
|
|
$
|
1,195,000
|
|
|
$
|
780,713
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
Secured Term Loan
|
|
$
|
110,000
|
|
(8)
|
$
|
110,000
|
|
|
LIBOR+5.00%
|
(8)
|
December 22, 2020
|
(8)
|
$
|
155,000
|
|
|
$
|
155,000
|
|
|
LIBOR+6.00%
|
|
December 9, 2018
|
(8)
|
Total
|
|
$
|
1,540,989
|
|
|
$
|
1,067,960
|
|
|
|
|
|
|
$
|
1,350,000
|
|
|
$
|
935,713
|
|
|
|
|
|
|
(1)
|
The maturity date of the master repurchase funding facility with Wells Fargo Bank, National Association (the “Wells Fargo Facility”) is subject to two 12-month extensions at our option provided that certain conditions are met and applicable extension fees are paid. In May 2017, we amended the Wells Fargo Facility to increase the facility’s commitment amount from $325.0 million to $500.0 million and extend the initial maturity date to December 14, 2018.
|
(2)
|
The maturity date of the master repurchase facility with Citibank, N.A. (the “Citibank Facility”) is subject to three 12-month extensions at our option provided that certain conditions are met and applicable extension fees are paid. The Citibank Facility has an accordion feature that provides for an increase in the $250.0 million commitment amount with respect to approved assets, as determined by Citibank, N.A. in its sole discretion.
|
(3)
|
Individual advances on loans under the Bridge Loan Warehousing Credit and Security Agreement with Bank of America, N.A. (the “BAML Facility”) generally have a two-year maturity, subject to a 12-month extension at our option provided that certain conditions are met and applicable extension fees are paid. In May 2017, we amended the BAML Facility to extend the period during which we may request individual loans under the facility to May 24, 2018. In October 2017, we amended the BAML Facility to decrease the interest rate on advances under the facility to a per annum rate equal to one-month LIBOR plus a spread of 2.00%.
|
(4)
|
The maturity date of the secured revolving funding facility with City National Bank (the “CNB Facility”) is subject to two 12-month extensions at our option provided that certain conditions are met and applicable extension fees are paid. In March 2017, we amended the CNB Facility to extend the initial maturity date to March 11, 2018. See “Recent Developments” and Note 15 to our consolidated financial statements included in this annual report on Form 10-K for a subsequent event.
|
(5)
|
The maturity date of the revolving master repurchase facility with Metropolitan Life Insurance Company (the “MetLife Facility”) is subject to two 12-month extensions at our option provided that certain conditions are met and applicable extension fees are paid. In August 2017, we amended the MetLife Facility to extend the initial maturity date to August 12, 2020 and decrease the interest rate on advances under the facility to a per annum rate equal to one-month LIBOR plus a spread of 2.30%.
|
(6)
|
The interest rate on advances under the revolving master repurchase facility with UBS Real Estate Securities Inc. (the “UBS Facility”) is one-month LIBOR plus (i) 1.88% per annum, for assets that are subject to an advance for one year or less, (ii) 2.08% per annum, for assets that are subject to an advance in excess of one year but less than two years, and (iii) 2.28% per annum, for assets that are subject to an advance for more than two years.
|
(7)
|
The maturity date of the master repurchase and securities contract with U.S. Bank National Association (the “U.S. Bank Facility”) is subject to two 12-month extensions at our option provided that certain conditions are met and applicable extension fees are paid. In June 2017, we amended the U.S. Bank Facility to increase the facility’s commitment amount from $125.0 million to $186.0 million and extend the initial maturity date to July 31, 2020.
|
(8)
|
In December 2017, we amended the Credit and Guaranty Agreement with the lenders referred to therein and Cortland Capital Market Services LLC, as administrative agent and collateral agent for the lenders (the “Secured Term Loan”), to, among other things, (i) decrease the interest rate on advances under the Secured Term Loan from a per annum rate equal to one-month LIBOR plus a spread of 6.00% (with a 1.00% LIBOR floor) to a per annum rate equal to one, two, three or six-month LIBOR plus a spread of 5.00% (with no LIBOR floor), (ii) extend the initial maturity date to December 22, 2020, (iii) decrease the commitment amount from $155.0 million to $110.0 million and (iv) add one 12-month extension to the initial maturity date, which may be exercised at our option, provided that there are no existing events of default under the Secured Term Loan.
|
|
Total
|
|
Less than
1 year |
|
1 to 3 years
|
|
3 to 5 years
|
|
More than
5 years |
||||||||||
Wells Fargo Facility
|
$
|
407,853
|
|
|
$
|
407,853
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
Citibank Facility
|
175,651
|
|
|
175,651
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||||
BAML Facility
|
78,320
|
|
|
78,320
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||||
CNB Facility
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||||
MetLife Facility
|
101,131
|
|
|
—
|
|
|
101,131
|
|
|
—
|
|
|
—
|
|
|||||
UBS Facility
|
34,000
|
|
|
34,000
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||||
U.S. Bank Facility
|
161,005
|
|
|
—
|
|
|
161,005
|
|
|
—
|
|
|
—
|
|
|||||
Secured Term Loan
|
110,000
|
|
|
—
|
|
|
110,000
|
|
|
—
|
|
|
—
|
|
|||||
Future Loan Funding Commitments
|
110,248
|
|
|
7,618
|
|
|
88,135
|
|
|
14,495
|
|
|
—
|
|
|||||
Total
|
$
|
1,178,208
|
|
|
$
|
703,442
|
|
|
$
|
460,271
|
|
|
$
|
14,495
|
|
|
$
|
—
|
|
Change in Average 30-Day LIBOR
|
|
For the year ended December 31, 2017
|
||
Up 300 basis points
|
|
$
|
10.8
|
|
Up 200 basis points
|
|
$
|
7.2
|
|
Up 100 basis points
|
|
$
|
3.6
|
|
Down to 0 basis points
|
|
$
|
1.8
|
|
1.
|
Financial Statements—See the Index to Consolidated Financial Statements on Page F-1.
|
2.
|
Financial Statement Schedules—None. We have omitted financial statement schedules because they are not required or are not applicable, or the required information is shown in the consolidated financial statements or notes to the consolidated financial statements.
|
3.
|
Exhibits.
|
Exhibit
Number
|
|
Exhibit Description
|
|
Subsidiaries of Ares Commercial Real Estate Corporation
|
|
|
Consent of Ernst & Young LLP
|
|
|
Certification of Chief Executive Officer pursuant to Rule 13a‑14(a) and Rule 15d‑14(a), as adopted pursuant to Section 302 of the Sarbanes‑Oxley Act of 2002
|
|
|
Certification of Chief Financial Officer pursuant to Rule 13a‑14(a) and Rule 15d‑14(a), as adopted pursuant to Section 302 of the Sarbanes‑Oxley Act of 2002
|
|
|
Certification of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes‑Oxley Act of 2002
|
|
101.INS
|
|
XBRL Instance Document
|
101.SCH
|
|
XBRL Taxonomy Extension Schema Document
|
101.CAL
|
|
XBRL Taxonomy Extension Calculation Linkbase Document
|
101.LAB
|
|
XBRL Taxonomy Extension Label Linkbase Document
|
101.PRE
|
|
XBRL Taxonomy Extension Presentation Linkbase Document
|
101.DEF
|
|
XBRL Taxonomy Extension Definition Linkbase Document
|
*
|
Previously filed
|
#
|
Denotes a management contract or compensatory plan or arrangement
|
(1)
|
Incorporated by reference to Exhibit 2.1 to the Company’s Form 8-K (File No. 001-35517), filed on June 29, 2016.
|
(2)
|
Incorporated by reference to Exhibit 3.1 to the Company’s Form 10-K (File No. 001-35517), filed on March 1, 2016.
|
(3)
|
Incorporated by reference to Exhibits 3.2 and 10.1, as applicable, to the Company’s Form S‑8 (File No. 333‑181077), filed on May 1, 2012
|
(4)
|
Incorporated by reference to Exhibits 10.1, 10.3, 10.4 and 10.5, as applicable, to the Company’s Form 8‑K (File No. 001‑35517), filed on May 4, 2012.
|
(5)
|
Incorporated by reference to Exhibit 10.17 to the Company’s Form 10‑K (File No. 001‑35517), filed on March 17, 2014.
|
(6)
|
Incorporated by reference to Exhibit 10.4 to the Company’s Registration Statement on Amendment No. 3 to Form S‑11/A (File No. 333‑176841), filed on April 12, 2012.
|
(7)
|
Incorporated by reference to Exhibit 10.7 to the Company’s Form 10‑Q (File No. 001‑35517), filed on November 13, 2013.
|
(8)
|
Incorporated by reference to Exhibits 10.1, 10.2, 10.3 and 10.4, as applicable, to the Company’s Form 8‑K (File No. 001‑35517), filed on March 14, 2014.
|
(9)
|
Incorporated by reference to Exhibits 10.1 and 10.2, as applicable, to the Company’s Form 8‑K (File No. 001‑35517), filed on April 15, 2014.
|
(10)
|
Incorporated by reference to Exhibits 10.1 and 10.2, as applicable, to the Company’s Form 8‑K (File No. 001‑35517), filed on August 18, 2014.
|
(11)
|
Incorporated by reference to Exhibits 10.1 and 10.2, as applicable, to the Company’s Form 8‑K (File No. 001‑35517), filed on December 12, 2014.
|
(12)
|
Incorporated by reference to Exhibits 10.6, as applicable, to the Company’s Form 8‑K (File No. 001‑35517), filed on July 31, 2014.
|
(13)
|
Incorporated by reference to Exhibits 10.1, 10.2 and 10.3, as applicable, to the Company’s Form 8‑K (File No. 001‑35517), filed on June 2, 2015.
|
(14)
|
Incorporated by reference to Exhibit 10.1 to the Company’s Form 8‑K (File No. 001‑35517), filed on October 26, 2015.
|
(15)
|
Incorporated by reference to Exhibits 10.1, 10.2 and 10.3, as applicable, to the Company’s Form 8‑K (File No. 001‑35517), filed on December 14, 2015.
|
(16)
|
Incorporated by reference to Exhibits 10.52 and 10.53, as applicable, to the Company’s Form 10-K (File No. 001-35517), filed on March 1, 2016.
|
(17)
|
Incorporated by reference to Exhibit 10.1 to the Company’s Form 8-K (file No. 001-35517), filed on June 1, 2016.
|
(18)
|
Incorporated by reference to Exhibits 10.4, 10.6, 10.8 and 10.9, as applicable, to the Company’s Form 10-Q (File No. 001-35517), filed on August 4, 2016.
|
(19)
|
Incorporated by reference to Exhibit 10.1 to the Company’s Form 8-K (File No. 001-35517), filed on July 19, 2016
|
(20)
|
Incorporated by reference to Exhibit 10.1 to the Company’s Form 8-K (File No. 001-35517), filed on August 11, 2016.
|
(21)
|
Incorporated by reference to Exhibit 10.11 to the Company’s Form 10-Q (File No. 001-35517), filed on November 3, 2016.
|
(22)
|
Incorporated by reference to Exhibit 10.1 to the Company’s Form 8-K (File No. 001-35517), filed on December 12, 2016.
|
(23)
|
Incorporated by reference to Exhibits 10.1, 10.2 and 10.3, as applicable, to the Company’s Form 10-Q (File No. 001-35517), filed on May 2, 2017.
|
(24)
|
Incorporated by reference to Exhibits 2.2, 10.1, 10.2, 10.3 and 10.6, as applicable, to the Company’s Form 10-Q (File No. 001-35517), filed on August 3, 2017.
|
(25)
|
Incorporated by reference to Exhibit 10.1 to the Company’s Form 8-K (File No. 001-35517), filed on May 30, 2017.
|
(26)
|
Incorporated by reference to Exhibit 10.1 to the Company’s Form 8-K (File No. 001-35517), filed on June 28, 2017.
|
(27)
|
Incorporated by reference to Exhibits 10.1 and 10.2, as applicable, to the Company’s Form 8-K (File No. 001-35517), filed on August 9, 2017.
|
(28)
|
Incorporated by reference to Exhibit 10.3 to the Company’s Form 10-Q (File No. 001-35517), filed on November 1, 2017.
|
(29)
|
Incorporated by reference to Exhibit 10.1 to the Company’s Form 8-K (File No. 001-35517), filed on October 3, 2017.
|
(30)
|
Incorporated by reference to Exhibit 10.1 to the Company’s Form 8-K (File No. 001-35517), filed on December 29, 2017.
|
|
As of December 31,
|
||||||
|
2017
|
|
2016
|
||||
ASSETS
|
|
|
|
||||
Cash and cash equivalents ($8 related to consolidated VIEs as of December 31, 2016)
|
$
|
28,343
|
|
|
$
|
47,270
|
|
Restricted cash
|
379
|
|
|
375
|
|
||
Loans held for investment ($341,158 and $21,514 related to consolidated VIEs, respectively)
|
1,726,283
|
|
|
1,313,937
|
|
||
Other assets ($945 and $203 of interest receivable related to consolidated VIEs, respectively)
|
15,214
|
|
|
12,121
|
|
||
Total assets
|
$
|
1,770,219
|
|
|
$
|
1,373,703
|
|
LIABILITIES AND EQUITY
|
|
|
|
||||
LIABILITIES
|
|
|
|
||||
Secured funding agreements
|
$
|
957,960
|
|
|
$
|
780,713
|
|
Secured term loan
|
107,595
|
|
|
149,878
|
|
||
Collateralized loan obligation securitization debt (consolidated VIE)
|
271,211
|
|
|
—
|
|
||
Due to affiliate
|
2,628
|
|
|
2,699
|
|
||
Dividends payable
|
7,722
|
|
|
7,406
|
|
||
Other liabilities ($414 of interest payable related to consolidated VIEs as of December 31, 2017)
|
3,933
|
|
|
3,334
|
|
||
Total liabilities
|
1,351,049
|
|
|
944,030
|
|
||
Commitments and contingencies (Note 5)
|
|
|
|
|
|
||
EQUITY
|
|
|
|
||||
Common stock, par value $0.01 per share, 450,000,000 shares authorized at December 31, 2017 and 2016, and 28,598,916 and 28,482,756 shares issued and outstanding at December 31, 2017 and 2016, respectively
|
283
|
|
|
283
|
|
||
Additional paid-in capital
|
420,637
|
|
|
420,056
|
|
||
Accumulated deficit
|
(1,750
|
)
|
|
(1,310
|
)
|
||
Total stockholders' equity
|
419,170
|
|
|
419,029
|
|
||
Non-controlling interests in consolidated VIEs
|
—
|
|
|
10,644
|
|
||
Total equity
|
419,170
|
|
|
429,673
|
|
||
Total liabilities and equity
|
$
|
1,770,219
|
|
|
$
|
1,373,703
|
|
|
For the years ended December 31,
|
||||||||||
|
2017
|
|
2016
|
|
2015
|
||||||
Net inte
rest margin:
|
|
|
|
|
|
||||||
Interest income from loans held for investment
|
$
|
97,541
|
|
|
$
|
81,963
|
|
|
$
|
86,337
|
|
Interest expense
|
(51,193
|
)
|
|
(36,856
|
)
|
|
(36,342
|
)
|
|||
Net interest margin
|
46,348
|
|
|
45,107
|
|
|
49,995
|
|
|||
Expenses:
|
|
|
|
|
|
|
|||||
Management and incentive fees to affiliate
|
6,569
|
|
|
5,956
|
|
|
5,397
|
|
|||
Professional fees
|
1,674
|
|
|
2,228
|
|
|
2,018
|
|
|||
General and administrative expenses
|
2,828
|
|
|
2,801
|
|
|
2,830
|
|
|||
General and administrative expenses reimbursed to affiliate
|
3,899
|
|
|
3,441
|
|
|
3,426
|
|
|||
Total expenses
|
14,970
|
|
|
14,426
|
|
|
13,671
|
|
|||
Early extinguishment of debt costs
|
(768
|
)
|
|
—
|
|
|
—
|
|
|||
Income from continuing operations before income taxes
|
30,610
|
|
|
30,681
|
|
|
36,324
|
|
|||
Income tax expense (benefit), including excise tax
|
178
|
|
|
230
|
|
|
(11
|
)
|
|||
Net income from continuing operations
|
30,432
|
|
|
30,451
|
|
|
36,335
|
|
|||
Net income from operations of discontinued operations, net of income taxes
|
—
|
|
|
4,221
|
|
|
6,985
|
|
|||
Gain on sale of discontinued operations
|
—
|
|
|
10,196
|
|
|
—
|
|
|||
Net income attributable to ACRE
|
30,432
|
|
|
44,868
|
|
|
43,320
|
|
|||
Less: Net income attributable to non-controlling interests
|
(25
|
)
|
|
(4,532
|
)
|
|
(9,035
|
)
|
|||
Net income attributable to common stockholders
|
$
|
30,407
|
|
|
$
|
40,336
|
|
|
$
|
34,285
|
|
Basic earnings per common share:
|
|
|
|
|
|
||||||
Continuing operations
|
$
|
1.07
|
|
|
$
|
0.91
|
|
|
$
|
0.96
|
|
Discontinued operations
|
—
|
|
|
0.51
|
|
|
0.25
|
|
|||
Net income
|
$
|
1.07
|
|
|
$
|
1.42
|
|
|
$
|
1.20
|
|
Diluted earnings per common share:
|
|
|
|
|
|
||||||
Continuing operations
|
$
|
1.07
|
|
|
$
|
0.91
|
|
|
$
|
0.95
|
|
Discontinued operations
|
—
|
|
|
0.51
|
|
|
0.24
|
|
|||
Net income
|
$
|
1.07
|
|
|
$
|
1.41
|
|
|
$
|
1.20
|
|
Weighted average number of common shares outstanding:
|
|
|
|
|
|
||||||
Basic weighted average shares of common stock outstanding
|
28,478,237
|
|
|
28,461,853
|
|
|
28,501,897
|
|
|||
Diluted weighted average shares of common stock outstanding
|
28,550,945
|
|
|
28,523,306
|
|
|
28,597,568
|
|
|
Common Stock
|
|
Additional
Paid-in
Capital
|
|
Accumulated
Deficit
|
|
Total Stockholders’ Equity
|
|
Non-Controlling
Interests
|
|
Total
Equity
|
|||||||||||||||
|
Shares
|
|
Amount
|
|||||||||||||||||||||||
Balance at December 31, 2014
|
28,586,915
|
|
|
$
|
284
|
|
|
$
|
420,344
|
|
|
$
|
(17,674
|
)
|
|
$
|
402,954
|
|
|
$
|
77,932
|
|
|
$
|
480,886
|
|
Stock‑based compensation
|
22,735
|
|
|
—
|
|
|
835
|
|
|
—
|
|
|
835
|
|
|
—
|
|
|
835
|
|
||||||
Net income
|
—
|
|
|
—
|
|
|
—
|
|
|
34,285
|
|
|
34,285
|
|
|
9,035
|
|
|
43,320
|
|
||||||
Dividends declared
|
—
|
|
|
—
|
|
|
—
|
|
|
(28,603
|
)
|
|
(28,603
|
)
|
|
—
|
|
|
(28,603
|
)
|
||||||
Contributions from non‑controlling interests
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
5,685
|
|
|
5,685
|
|
||||||
Distributions to non-controlling interests
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(45,635
|
)
|
|
(45,635
|
)
|
||||||
Balance at December 31, 2015
|
28,609,650
|
|
|
$
|
284
|
|
|
$
|
421,179
|
|
|
$
|
(11,992
|
)
|
|
$
|
409,471
|
|
|
$
|
47,017
|
|
|
$
|
456,488
|
|
Stock‑based compensation
|
3,022
|
|
|
—
|
|
|
312
|
|
|
—
|
|
|
312
|
|
|
—
|
|
|
312
|
|
||||||
Repurchase and retirement of common stock
|
(129,916
|
)
|
|
(1
|
)
|
|
(1,435
|
)
|
|
—
|
|
|
(1,436
|
)
|
|
—
|
|
|
(1,436
|
)
|
||||||
Net income
|
—
|
|
|
—
|
|
|
—
|
|
|
40,336
|
|
|
40,336
|
|
|
4,532
|
|
|
44,868
|
|
||||||
Dividends declared
|
—
|
|
|
—
|
|
|
—
|
|
|
(29,654
|
)
|
|
(29,654
|
)
|
|
—
|
|
|
(29,654
|
)
|
||||||
Contributions from non-controlling interests
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
11
|
|
|
11
|
|
||||||
Distributions to non-controlling interests
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(40,916
|
)
|
|
(40,916
|
)
|
||||||
Balance at December 31, 2016
|
28,482,756
|
|
|
$
|
283
|
|
|
$
|
420,056
|
|
|
$
|
(1,310
|
)
|
|
$
|
419,029
|
|
|
$
|
10,644
|
|
|
$
|
429,673
|
|
Stock‑based compensation
|
116,160
|
|
|
—
|
|
|
581
|
|
|
—
|
|
|
581
|
|
|
—
|
|
|
581
|
|
||||||
Net income
|
—
|
|
|
—
|
|
|
—
|
|
|
30,407
|
|
|
30,407
|
|
|
25
|
|
|
30,432
|
|
||||||
Dividends declared
|
—
|
|
|
—
|
|
|
—
|
|
|
(30,847
|
)
|
|
(30,847
|
)
|
|
—
|
|
|
(30,847
|
)
|
||||||
Contributions from non-controlling interests
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
12
|
|
|
12
|
|
||||||
Distributions to non-controlling interests
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(10,681
|
)
|
|
(10,681
|
)
|
||||||
Balance at December 31, 2017
|
28,598,916
|
|
|
$
|
283
|
|
|
$
|
420,637
|
|
|
$
|
(1,750
|
)
|
|
$
|
419,170
|
|
|
$
|
—
|
|
|
$
|
419,170
|
|
|
For the years ended December 31,
|
||||||||||
|
2017
|
|
2016
|
|
2015
|
||||||
Operating activities:
|
|
|
|
|
|
||||||
Net income
|
$
|
30,432
|
|
|
$
|
44,868
|
|
|
$
|
43,320
|
|
Adjustments to reconcile net income to net cash provided by (used in) operating activities (inclusive of amounts related to discontinued operations):
|
|
|
|
|
|
||||||
Amortization of deferred financing costs
|
7,608
|
|
|
6,439
|
|
|
9,559
|
|
|||
Change in mortgage banking activities
|
—
|
|
|
(10,386
|
)
|
|
(12,596
|
)
|
|||
Change in fair value of mortgage servicing rights
|
—
|
|
|
6,457
|
|
|
8,798
|
|
|||
Accretion of deferred loan origination fees and costs
|
(6,578
|
)
|
|
(5,924
|
)
|
|
(4,979
|
)
|
|||
Provision for loss sharing
|
—
|
|
|
(146
|
)
|
|
(1,093
|
)
|
|||
Cash paid to settle loss sharing obligations
|
—
|
|
|
(681
|
)
|
|
(2,264
|
)
|
|||
Originations of mortgage loans held for sale
|
—
|
|
|
(639,413
|
)
|
|
(681,928
|
)
|
|||
Sale of mortgage loans held for sale to third parties
|
—
|
|
|
571,714
|
|
|
850,816
|
|
|||
Stock-based compensation
|
581
|
|
|
312
|
|
|
835
|
|
|||
Early extinguishment of debt costs
|
768
|
|
|
—
|
|
|
—
|
|
|||
Gain on sale of discontinued operations
|
—
|
|
|
(10,196
|
)
|
|
—
|
|
|||
Depreciation expense
|
—
|
|
|
167
|
|
|
219
|
|
|||
Deferred tax expense
|
—
|
|
|
2,049
|
|
|
2,093
|
|
|||
Changes in operating assets and liabilities:
|
|
|
|
|
|
||||||
Restricted cash
|
(4
|
)
|
|
1,415
|
|
|
38,956
|
|
|||
Other assets
|
(2,530
|
)
|
|
40,016
|
|
|
20,040
|
|
|||
Due to affiliate
|
(71
|
)
|
|
380
|
|
|
(77
|
)
|
|||
Other liabilities
|
1,066
|
|
|
1,467
|
|
|
3,820
|
|
|||
Net cash provided by (used in) operating activities
|
31,272
|
|
|
8,538
|
|
|
275,519
|
|
|||
Investing activities:
|
|
|
|
|
|
|
|||||
Issuance of and fundings on loans held for investment
|
(900,289
|
)
|
|
(861,444
|
)
|
|
(228,500
|
)
|
|||
Principal repayment of loans held for investment
|
411,298
|
|
|
721,684
|
|
|
411,740
|
|
|||
Proceeds from sale of mortgage loans held for sale
|
73,900
|
|
|
—
|
|
|
74,625
|
|
|||
Receipt of origination fees
|
9,323
|
|
|
6,813
|
|
|
1,078
|
|
|||
Proceeds from sale of discontinued operations, net of cash sold
|
—
|
|
|
89,981
|
|
|
—
|
|
|||
Purchases of other assets
|
—
|
|
|
(354
|
)
|
|
(604
|
)
|
|||
Net cash provided by (used in) investing activities
|
(405,768
|
)
|
|
(43,320
|
)
|
|
258,339
|
|
|||
Financing activities:
|
|
|
|
|
|
||||||
Proceeds from secured funding agreements
|
923,882
|
|
|
1,288,698
|
|
|
345,434
|
|
|||
Repayments of secured funding agreements
|
(746,635
|
)
|
|
(1,030,760
|
)
|
|
(375,458
|
)
|
|||
Payment of secured funding costs
|
(8,405
|
)
|
|
(5,563
|
)
|
|
(8,013
|
)
|
|||
Proceeds from issuance of debt of consolidated VIEs
|
272,927
|
|
|
—
|
|
|
—
|
|
|||
Repayments of debt of consolidated VIEs
|
—
|
|
|
(255,275
|
)
|
|
(272,471
|
)
|
|||
Proceeds from warehouse lines of credit
|
—
|
|
|
863,382
|
|
|
804,935
|
|
|||
Repayments of warehouse lines of credit
|
—
|
|
|
(795,684
|
)
|
|
(973,294
|
)
|
|||
Proceeds from secured term loan
|
—
|
|
|
80,000
|
|
|
75,000
|
|
|||
Repayments of secured term loan
|
(45,000
|
)
|
|
—
|
|
|
—
|
|
|||
Repayment of convertible debt
|
—
|
|
|
—
|
|
|
(69,000
|
)
|
|||
Repurchase of common stock
|
—
|
|
|
(1,436
|
)
|
|
—
|
|
|||
Dividends paid
|
(30,531
|
)
|
|
(29,400
|
)
|
|
(28,597
|
)
|
|||
Contributions from non-controlling interests
|
12
|
|
|
11
|
|
|
5,685
|
|
|||
Distributions to non-controlling interests
|
(10,681
|
)
|
|
(40,916
|
)
|
|
(45,635
|
)
|
|||
Net cash provided by (used in) financing activities
|
355,569
|
|
|
73,057
|
|
|
(541,414
|
)
|
|||
Change in cash and cash equivalents
|
(18,927
|
)
|
|
38,275
|
|
|
(7,556
|
)
|
|||
Cash and cash equivalents of continuing operations, beginning of period
|
47,270
|
|
|
5,066
|
|
|
15,045
|
|
|||
Cash and cash equivalents of discontinued operations, beginning of period
|
—
|
|
|
3,929
|
|
|
1,506
|
|
|||
Cash and cash equivalents, end of period
|
$
|
28,343
|
|
|
$
|
47,270
|
|
|
$
|
8,995
|
|
Cash and cash equivalents of continuing operations, end of period
|
$
|
28,343
|
|
|
$
|
47,270
|
|
|
$
|
5,066
|
|
Cash and cash equivalents of discontinued operations, end of period
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
3,929
|
|
Supplemental Information:
|
|
|
|
|
|
||||||
Interest paid during the period
|
$
|
41,891
|
|
|
$
|
30,066
|
|
|
$
|
28,731
|
|
Income taxes paid during the period
|
$
|
240
|
|
|
$
|
—
|
|
|
$
|
83
|
|
Supplemental disclosure of noncash investing and financing activities:
|
|
|
|
|
|
||||||
Dividends declared, but not yet paid
|
$
|
7,722
|
|
|
$
|
7,406
|
|
|
$
|
7,152
|
|
Notes receivable related to consolidated VIEs
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
35,607
|
|
|
|
For the years ended December 31,
|
||||||||||
|
|
2017
|
|
2016
|
|
2015
|
||||||
Interest income from loans held for investment, excluding non-controlling interests
|
|
$
|
97,506
|
|
|
$
|
77,424
|
|
|
$
|
77,278
|
|
Interest income from non-controlling interest investment held by third parties
|
|
35
|
|
|
4,539
|
|
|
9,059
|
|
|||
Interest income from loans held for investment
|
|
$
|
97,541
|
|
|
$
|
81,963
|
|
|
$
|
86,337
|
|
|
For the years ended December 31,
|
||||||||||
|
2017
|
|
2016
|
|
2015
|
||||||
Secured funding agreements and securitizations debt
|
$
|
37,602
|
|
|
$
|
27,856
|
|
|
$
|
29,740
|
|
Secured term loan
|
13,591
|
|
|
9,000
|
|
|
388
|
|
|||
Convertible notes
|
—
|
|
|
—
|
|
|
6,214
|
|
|||
Interest expense
|
$
|
51,193
|
|
|
$
|
36,856
|
|
|
$
|
36,342
|
|
|
As of December 31, 2017
|
||||||||||||||
|
Carrying Amount (1)
|
|
Outstanding Principal (1)
|
|
Weighted Average Minimum Loan Borrowing Spread (2)
|
|
Weighted Average Unleveraged Effective Yield (3)
|
|
Weighted Average Remaining Life (Years)
|
||||||
Senior mortgage loans
|
$
|
1,674,169
|
|
|
$
|
1,684,439
|
|
|
4.8
|
%
|
|
6.2
|
%
|
|
1.9
|
Subordinated debt and preferred equity investments
|
52,114
|
|
|
52,847
|
|
|
9.5
|
%
|
|
10.8
|
%
|
|
3.4
|
||
Total loans held for investment portfolio
|
$
|
1,726,283
|
|
|
$
|
1,737,286
|
|
|
5.0
|
%
|
|
6.3
|
%
|
|
2.0
|
|
As of December 31, 2016
|
||||||||||||||
|
Carrying Amount (1)
|
|
Outstanding Principal (1)
|
|
Weighted Average Minimum Loan Borrowing Spread (2)
|
|
Weighted Average Unleveraged Effective Yield (3)
|
|
Weighted Average Remaining Life (Years)
|
||||||
Senior mortgage loans
|
$
|
1,181,569
|
|
|
$
|
1,188,425
|
|
|
4.7
|
%
|
|
5.7
|
%
|
|
1.8
|
Subordinated debt and preferred equity investments
|
121,828
|
|
|
123,230
|
|
|
10.7
|
%
|
|
11.5
|
%
|
|
4.1
|
||
Total loans held for investment portfolio (excluding non-controlling interests held by third parties) (4)
|
$
|
1,303,397
|
|
|
$
|
1,311,655
|
|
|
5.2
|
%
|
|
6.3
|
%
|
|
2.0
|
(1)
|
The difference between the Carrying Amount and the Outstanding Principal amount of the loans held for investment consists of unamortized purchase discount, deferred loan fees and loan origination costs.
|
(2)
|
Minimum Loan Borrowing Spread is equal to (a) for floating rate loans, the margin above the applicable index rate (e.g., LIBOR) plus floors, if any, on such applicable index rates, and (b) for fixed rate loans, the applicable interest rate.
|
(3)
|
Unleveraged Effective Yield is the compounded effective rate of return that would be earned over the life of the investment based on the contractual interest rate (adjusted for any deferred loan fees, costs, premium or discount) and assumes
no
dispositions, early prepayments or defaults. The Total Weighted Average Unleveraged Effective Yield is calculated based on the average of Unleveraged Effective Yield of all loans held by the Company
as of December 31, 2017 and 2016
as weighted by the Outstanding Principal balance of each loan.
|
(4)
|
The table above, as of
December 31, 2016
, excludes non-controlling interests held by third parties. A reconciliation of the Carrying Amount of loans held for investment portfolio, excluding non-controlling interests held by third parties, to the Carrying Amount of loans held for investment, as included in the Company’s consolidated balance sheets, is presented below.
|
|
As of December 31, 2016
|
||||||
|
Carrying Amount
|
|
Outstanding Principal
|
||||
Total loans held for investment portfolio (excluding non-controlling interests held by third parties)
|
$
|
1,303,397
|
|
|
$
|
1,311,655
|
|
Non-controlling interest investment held by third parties
|
10,540
|
|
|
10,540
|
|
||
Loans held for investment
|
$
|
1,313,937
|
|
|
$
|
1,322,195
|
|
Loan Type
|
|
Location
|
|
Outstanding Principal (1)
|
|
Carrying Amount (1)
|
|
Interest Rate
|
|
Unleveraged Effective Yield (2)
|
|
Maturity Date (3)
|
|
Payment Terms (4)
|
|
Senior Mortgage Loans:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Various
|
(5)
|
Diversified
|
|
$134.1
|
|
$133.7
|
|
L+4.35%
|
|
6.6%
|
|
Oct 2018
|
|
I/O
|
|
Office
|
|
TX
|
|
96.9
|
|
96.0
|
|
L+3.60%
|
|
5.7%
|
|
July 2020
|
|
I/O
|
|
Multifamily
|
|
FL
|
|
89.7
|
|
89.4
|
|
L+4.75%
|
|
6.9%
|
|
Sep 2019
|
|
I/O
|
|
Various
|
(6)
|
Diversified
|
|
82.3
|
|
82.0
|
|
L+4.75%
|
|
7.0%
|
|
Oct 2018
|
|
I/O
|
|
Mixed-use
|
|
NY
|
|
65.6
|
|
65.4
|
|
L+4.16%
|
|
6.2%
|
|
Apr 2019
|
|
I/O
|
|
Multifamily
|
|
UT
|
|
62.0
|
|
61.5
|
|
L+3.25%
|
|
5.1%
|
|
Dec 2020
|
|
I/O
|
|
Office
|
|
IL
|
|
60.4
|
|
59.8
|
|
L+3.75%
|
|
5.9%
|
|
Dec 2020
|
|
I/O
|
|
Office
|
|
IL
|
|
58.5
|
|
58.2
|
|
L+3.99%
|
|
6.0%
|
|
Aug 2019
|
|
I/O
|
|
Office
|
|
CA
|
|
57.7
|
|
57.4
|
|
L+4.40%
|
|
6.5%
|
|
Aug 2019
|
|
I/O
|
|
Office
|
|
CO
|
|
54.0
|
|
53.5
|
|
L+4.15%
|
|
6.1%
|
|
June 2021
|
|
I/O
|
|
Multifamily
|
|
FL
|
|
53.8
|
|
53.3
|
|
L+3.65%
|
|
5.6%
|
|
Mar 2021
|
|
I/O
|
|
Industrial
|
|
MN
|
|
51.6
|
|
51.0
|
|
L+3.15%
|
|
5.2%
|
|
Dec 2020
|
|
I/O
|
|
Office
|
|
NJ
|
|
48.5
|
|
48.1
|
|
L+4.65%
|
|
6.8%
|
|
July 2020
|
|
I/O
|
|
Multifamily
|
|
FL
|
|
45.4
|
|
45.2
|
|
L+4.75%
|
|
6.9%
|
|
Sep 2019
|
|
I/O
|
|
Multifamily
|
|
TX
|
|
42.7
|
|
42.4
|
|
L+3.30%
|
|
5.2%
|
|
Dec 2020
|
|
I/O
|
|
Student Housing
|
|
CA
|
|
41.8
|
|
41.4
|
|
L+3.95%
|
|
6.1%
|
|
July 2020
|
|
I/O
|
|
Student Housing
|
|
TX
|
|
40.1
|
|
39.7
|
|
L+4.75%
|
|
6.9%
|
|
Jan 2021
|
|
I/O
|
|
Hotel
|
|
CA
|
|
40.0
|
|
39.6
|
|
L+4.12%
|
|
6.0%
|
|
Jan 2021
|
|
I/O
|
|
Student Housing
|
|
NC
|
|
38.7
|
|
38.4
|
|
L+4.75%
|
|
7.4%
|
|
Feb 2019
|
|
I/O
|
|
Hotel
|
|
NY
|
|
38.6
|
|
38.6
|
|
L+4.75%
|
|
6.7%
|
|
June 2018
|
|
I/O
|
|
Hotel
|
|
MI
|
|
35.2
|
|
35.2
|
|
L+4.15%
|
|
5.7%
|
|
July 2018
|
(7)
|
I/O
|
|
Multifamily
|
|
MN
|
|
34.1
|
|
33.9
|
|
L+4.75%
|
|
6.8%
|
|
Oct 2019
|
|
I/O
|
|
Industrial
|
|
OH
|
|
32.2
|
|
32.2
|
|
L+4.20%
|
|
6.1%
|
|
May 2018
|
|
P/I
|
(8)
|
Office
|
|
OR
|
|
32.0
|
|
31.9
|
|
L+3.75%
|
|
5.7%
|
|
Oct 2018
|
|
I/O
|
|
Multifamily
|
|
NY
|
|
31.3
|
|
31.2
|
|
L+4.55%
|
|
6.6%
|
|
Feb 2019
|
|
I/O
|
|
Multifamily
|
|
NY
|
|
29.6
|
|
29.5
|
|
L+3.75%
|
|
5.6%
|
|
Oct 2018
|
(9)
|
P/I
|
(8)
|
Multifamily
|
|
NY
|
|
29.4
|
|
29.1
|
|
L+3.20%
|
|
5.1%
|
|
Dec 2020
|
|
I/O
|
|
Multifamily
|
|
TX
|
|
27.5
|
|
27.3
|
|
L+3.20%
|
|
5.3%
|
|
Oct 2020
|
|
I/O
|
|
Multifamily
|
|
TX
|
|
26.3
|
|
26.2
|
|
L+3.80%
|
|
5.5%
|
|
Jan 2019
|
|
I/O
|
|
Multifamily
|
|
CA
|
|
25.5
|
|
25.3
|
|
L+3.85%
|
|
5.9%
|
|
July 2020
|
|
I/O
|
|
Student Housing
|
|
AL
|
|
24.1
|
|
23.9
|
|
L+4.45%
|
|
6.6%
|
|
Feb 2020
|
|
I/O
|
|
Student Housing
|
|
TX
|
|
24.0
|
|
23.8
|
|
L+4.10%
|
|
6.2%
|
|
Jan 2021
|
|
I/O
|
|
Multifamily
|
|
CA
|
|
22.3
|
|
22.2
|
|
L+3.90%
|
|
5.8%
|
|
Mar 2021
|
|
I/O
|
|
Multifamily
|
|
FL
|
|
22.2
|
|
22.1
|
|
L+4.25%
|
|
6.5%
|
|
Feb 2019
|
|
I/O
|
|
Office
|
|
PA
|
|
19.6
|
|
19.5
|
|
L+4.70%
|
|
6.7%
|
|
Mar 2020
|
|
I/O
|
|
Office
|
|
FL
|
|
18.4
|
|
18.3
|
|
L+4.30%
|
|
6.4%
|
|
Apr 2020
|
|
I/O
|
|
Multifamily
|
|
FL
|
|
18.3
|
|
18.2
|
|
L+4.00%
|
|
5.9%
|
|
Nov 2020
|
|
I/O
|
|
Multifamily
|
|
NY
|
|
16.3
|
|
16.3
|
|
L+4.35%
|
|
6.2%
|
|
Nov 2018
|
|
I/O
|
|
Multifamily
|
|
CA
|
|
13.7
|
|
13.5
|
|
L+3.80%
|
|
5.8%
|
|
July 2020
|
|
I/O
|
|
Subordinated Debt and Preferred Equity Investments:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Multifamily
|
|
NY
|
|
33.3
|
|
33.2
|
|
L+8.07%
|
|
9.9%
|
|
Jan 2019
|
|
I/O
|
|
Office
|
|
NJ
|
|
17.0
|
|
16.3
|
|
12.00%
|
|
12.8%
|
|
Jan 2026
|
|
I/O
|
(8)
|
Office
|
|
CA
|
|
2.6
|
|
2.6
|
|
L+8.25%
|
|
10.0%
|
|
Nov 2021
|
|
I/O
|
|
Total/Weighted Average
|
|
|
|
$1,737.3
|
|
$1,726.3
|
|
|
|
6.3%
|
|
|
|
|
|
(1)
|
The difference between the Carrying Amount and the Outstanding Principal amount of the loans held for investment consists of unamortized purchase discount, deferred loan fees and loan origination costs.
|
(2)
|
Unleveraged Effective Yield is the compounded effective rate of return that would be earned over the life of the investment based on the contractual interest rate (adjusted for any deferred loan fees, costs, premium or discount) and assumes no dispositions, early prepayments or defaults. Unleveraged Effective Yield for each loan is calculated based on LIBOR as of
December 31, 2017
or the LIBOR floor, as applicable. The Weighted Average Unleveraged Effective Yield is calculated based on the average of Unleveraged Effective Yield of all loans held by the Company as of
December 31, 2017
as weighted by the Outstanding Principal balance of each loan.
|
(3)
|
Certain loans are subject to contractual extension options that vary between
one
and
two
12
-month extensions and may be subject to performance based or other conditions as stipulated in the loan agreement. Actual maturities may differ from contractual maturities stated herein as certain borrowers may have the right to prepay with or without paying a prepayment penalty. The Company may also extend contractual maturities and amend other terms of the loans in connection with loan modifications.
|
(4)
|
I/O = interest only, P/I = principal and interest.
|
(5)
|
The senior mortgage loan is collateralized by a portfolio of self-storage properties and one retail property. The total principal balance of the senior mortgage loan is
$134.1 million
as of
December 31, 2017
, of which
$119.0 million
is allocable to the self-storage properties and
$15.1 million
is allocable to the retail property. In December 2017, the Company and the borrower entered into a loan modification, which, among other things, extended the repayment obligation with respect to the retail property to January 2018, which is prior to the initial maturity date of the loan in October 2018. See below in Note 3 included in these consolidated financial statements for further discussion of this loan.
|
(6)
|
The senior mortgage loan is collateralized by a portfolio of self-storage properties and one retail property. The total principal balance of the senior mortgage loan is
$82.3 million
as of
December 31, 2017
, of which
$70.2 million
is allocable to the self-storage properties and
$12.1 million
is allocable to the retail property. In December 2017, the Company and the borrower entered into a loan modification, which, among other things, extended the repayment obligation with respect to the retail property to the maturity date of the loan in October 2018. See below in Note 3 included in these consolidated financial statements for further discussion of this loan.
|
(7)
|
In April 2017, the borrower exercised a one-year extension option in accordance with the loan agreement, which extended the maturity date on the senior Michigan loan to July 2018.
|
(8)
|
In May 2017, amortization began on the senior Ohio loan, which had an outstanding principal balance of
$32.2 million
as of
December 31, 2017
. In October 2017, amortization began on the senior New York loan, which had an outstanding principal balance of
$29.6 million
as of
December 31, 2017
. In February 2021, amortization will begin on the subordinated New Jersey loan, which had an outstanding principal balance of
$17.0 million
as of
December 31, 2017
. The remainder of the loans in the Company’s portfolio are non-amortizing through their primary terms.
|
(9)
|
In August 2017, the borrower exercised a one-year extension option in accordance with the loan agreement, which extended the maturity date on the senior New York loan to October 2018.
|
Balance at December 31, 2015
|
$
|
1,174,391
|
|
Initial funding
|
830,092
|
|
|
Origination fees and discounts, net of costs
|
(8,152
|
)
|
|
Additional funding
|
33,366
|
|
|
Amortizing payments
|
(463
|
)
|
|
Loan payoffs
|
(721,221
|
)
|
|
Origination fee accretion
|
5,924
|
|
|
Balance at December 31, 2016
|
$
|
1,313,937
|
|
Initial funding
|
878,834
|
|
|
Origination fees and discounts, net of costs
|
(9,323
|
)
|
|
Additional funding
|
21,455
|
|
|
Amortizing payments
|
(509
|
)
|
|
Loan payoffs
|
(410,789
|
)
|
|
Loans sold to third parties (1)
|
(73,900
|
)
|
|
Origination fee accretion
|
6,578
|
|
|
Balance at December 31, 2017
|
$
|
1,726,283
|
|
(1)
|
In December 2017, the Company sold a senior mortgage loan and a B-Note mortgage loan with outstanding principal of
$63.9 million
and
$10.0 million
, respectively, which were both collateralized by an office property located in Texas, to a third party. Both loans were previously classified as held for investment and were sold in order to rebalance and optimize the Company’s loan portfolio. No gain or loss was recognized on the sale.
|
|
As of December 31,
|
|
||||||||||||||
|
2017
|
|
2016
|
|
||||||||||||
|
Outstanding Balance
|
|
Total
Commitment |
|
Outstanding Balance
|
|
Total
Commitment |
|
||||||||
Wells Fargo Facility
|
$
|
407,853
|
|
|
$
|
500,000
|
|
(1)
|
$
|
218,064
|
|
|
$
|
325,000
|
|
|
Citibank Facility
|
175,651
|
|
|
250,000
|
|
(2)
|
302,240
|
|
|
250,000
|
|
|
||||
BAML Facility
|
78,320
|
|
|
125,000
|
|
|
77,679
|
|
|
125,000
|
|
|
||||
CNB Facility
|
—
|
|
|
50,000
|
|
|
—
|
|
|
50,000
|
|
|
||||
MetLife Facility
|
101,131
|
|
|
180,000
|
|
|
53,130
|
|
|
180,000
|
|
|
||||
UBS Facility
|
34,000
|
|
|
140,000
|
|
|
71,360
|
|
|
140,000
|
|
|
||||
U.S. Bank Facility
|
161,005
|
|
|
185,989
|
|
(3)
|
58,240
|
|
|
125,000
|
|
|
||||
Secured Term Loan
|
110,000
|
|
|
110,000
|
|
(4)
|
155,000
|
|
|
155,000
|
|
|
||||
Total
|
$
|
1,067,960
|
|
|
$
|
1,540,989
|
|
|
$
|
935,713
|
|
|
$
|
1,350,000
|
|
|
(1)
|
In May 2017, the Company amended the Wells Fargo Facility (as defined below) to increase the facility’s commitment amount from
$325.0 million
to
$500.0 million
.
|
(2)
|
The Citibank Facility (as defined below) has an accordion feature that provides for an increase in the
$250.0 million
commitment amount with respect to approved assets, as determined by Citibank, N.A. in its sole discretion.
|
(3)
|
In June 2017, the Company amended the U.S. Bank Facility (as defined below) to increase the facility’s commitment amount from
$125.0 million
to
$186.0 million
.
|
(4)
|
In December 2017, the Company amended the Secured Term Loan (as defined below) to decrease the facility’s commitment amount from
$155.0 million
to
$110.0 million
.
|
|
Wells Fargo
Facility |
|
Citibank
Facility |
|
BAML Facility
|
|
CNB
Facility
|
|
MetLife Facility
|
|
UBS
Facility
|
|
U.S. Bank Facility
|
|
Secured Term Loan
|
|
Total
|
||||||||||||||||||
2018
|
$
|
407,853
|
|
|
$
|
175,651
|
|
|
$
|
78,320
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
34,000
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
695,824
|
|
2019
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||||||||
2020
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
101,131
|
|
|
—
|
|
|
161,005
|
|
|
110,000
|
|
|
372,136
|
|
|||||||||
2021
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||||||||
2022
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||||||||
Thereafter
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||||||||
|
$
|
407,853
|
|
|
$
|
175,651
|
|
|
$
|
78,320
|
|
|
$
|
—
|
|
|
$
|
101,131
|
|
|
$
|
34,000
|
|
|
$
|
161,005
|
|
|
$
|
110,000
|
|
|
$
|
1,067,960
|
|
|
As of December 31,
|
||||||
|
2017
|
|
2016
|
||||
Total commitments
|
$
|
1,847,534
|
|
|
$
|
1,380,805
|
|
Less: funded commitments
|
(1,737,286
|
)
|
|
(1,311,655
|
)
|
||
Total unfunded commitments
|
$
|
110,248
|
|
|
$
|
69,150
|
|
Grant Date
|
|
Vesting Start Date
|
|
Shares Granted
|
May 1, 2012
|
|
July 1, 2012
|
|
35,135
|
June 18, 2012
|
|
July 1, 2012
|
|
7,027
|
July 9, 2012
|
|
October 1, 2012
|
|
25,000
|
June 26, 2013
|
|
July 1, 2013
|
|
22,526
|
November 25, 2013
|
|
November 25, 2016
|
|
30,381
|
January 31, 2014
|
|
August 31, 2015
|
|
48,273
|
February 26, 2014
|
|
February 26, 2014
|
|
12,030
|
February 27, 2014
|
|
August 27, 2014
|
|
22,354
|
June 24, 2014
|
|
June 24, 2014
|
|
17,658
|
June 24, 2015
|
|
July 1, 2015
|
|
25,555
|
April 25, 2016
|
|
July 1, 2016
|
|
10,000
|
June 27, 2016
|
|
July 1, 2016
|
|
24,680
|
April 25, 2017
|
|
April 25, 2018
|
|
81,710
|
June 7, 2017
|
|
July 1, 2017
|
|
18,224
|
October 17, 2017
|
|
January 2, 2018
|
|
7,278
|
December 15, 2017
|
|
January 2, 2018
|
|
8,948
|
Total
|
|
|
|
396,779
|
|
Restricted Stock Grants—Directors
|
|
Restricted Stock Grants—Officers
|
|
Total
|
|||
Balance at December 31, 2016
|
21,514
|
|
|
—
|
|
|
21,514
|
|
Granted
|
25,502
|
|
|
90,658
|
|
|
116,160
|
|
Vested
|
(25,622
|
)
|
|
—
|
|
|
(25,622
|
)
|
Forfeited
|
—
|
|
|
—
|
|
|
—
|
|
Balance at December 31, 2017
|
21,394
|
|
|
90,658
|
|
|
112,052
|
|
|
Restricted Stock Grants—Directors
|
|
Restricted Stock Grants—Officers
|
|
Total
|
|||
2018
|
16,390
|
|
|
36,185
|
|
|
52,575
|
|
2019
|
3,336
|
|
|
27,237
|
|
|
30,573
|
|
2020
|
1,668
|
|
|
27,236
|
|
|
28,904
|
|
2021
|
—
|
|
|
—
|
|
|
—
|
|
2022
|
—
|
|
|
—
|
|
|
—
|
|
Total
|
21,394
|
|
|
90,658
|
|
|
112,052
|
|
|
For the years ended December 31,
|
||||||||||||||||||||||||||||||||||||||||||||||
|
2017
|
|
2016
|
|
2015
|
||||||||||||||||||||||||||||||||||||||||||
|
Restricted Stock Grants
|
|
Restricted Stock Grants
|
|
Restricted Stock Grants
|
||||||||||||||||||||||||||||||||||||||||||
|
Directors
|
|
Officers
|
|
Employees
|
|
Total
|
|
Directors
|
|
Officers
|
|
Employees
|
|
Total
|
|
Directors
|
|
Officers
|
|
Employees
|
|
Total
|
||||||||||||||||||||||||
Compensation expense (1)
|
$
|
317
|
|
|
$
|
264
|
|
|
$
|
—
|
|
|
$
|
581
|
|
|
$
|
355
|
|
|
$
|
53
|
|
|
$
|
(96
|
)
|
|
$
|
312
|
|
|
$
|
330
|
|
|
$
|
106
|
|
|
$
|
399
|
|
|
$
|
835
|
|
Total fair value of shares vested (2)
|
347
|
|
|
—
|
|
|
—
|
|
|
347
|
|
|
342
|
|
|
54
|
|
|
383
|
|
|
779
|
|
|
313
|
|
|
72
|
|
|
201
|
|
|
586
|
|
||||||||||||
Weighted average grant date fair value
|
338
|
|
|
1,254
|
|
|
—
|
|
|
1,592
|
|
|
412
|
|
|
—
|
|
|
—
|
|
|
412
|
|
|
299
|
|
|
—
|
|
|
—
|
|
|
299
|
|
(1)
|
Compensation expense for ACRE Capital employees is included within compensation and benefits expense for the years ended December 31, 2016 and 2015 in the reconciliation of net income from operations of discontinued operations, net of income taxes. See Note
13
included in these consolidated financial statements for more information.
|
(2)
|
Based on the closing price of the Company’s common stock on the NYSE on each vesting date.
|
|
For the years ended December 31,
|
||||||||||
|
2017
|
|
2016
|
|
2015
|
||||||
Net income from continuing operations, less non-controlling interests
|
$
|
30,407
|
|
|
$
|
25,919
|
|
|
$
|
27,300
|
|
Net income from discontinued operations, including gain on sale of discontinued operations
|
$
|
—
|
|
|
$
|
14,417
|
|
|
$
|
6,985
|
|
Divided by:
|
|
|
|
|
|
|
|||||
Basic weighted average shares of common stock outstanding:
|
28,478,237
|
|
|
28,461,853
|
|
|
28,501,897
|
|
|||
Non-vested restricted stock
|
72,708
|
|
|
61,453
|
|
|
95,671
|
|
|||
Diluted weighted average shares of common stock outstanding:
|
28,550,945
|
|
|
28,523,306
|
|
|
28,597,568
|
|
|||
Basic earnings per common share (1):
|
|
|
|
|
|
|
|||||
Continuing operations
|
$
|
1.07
|
|
|
$
|
0.91
|
|
|
$
|
0.96
|
|
Discontinued operations
|
—
|
|
|
0.51
|
|
|
0.25
|
|
|||
Net income
|
$
|
1.07
|
|
|
$
|
1.42
|
|
|
$
|
1.20
|
|
Diluted earnings per common share (1):
|
|
|
|
|
|
|
|||||
Continuing operations
|
$
|
1.07
|
|
|
$
|
0.91
|
|
|
$
|
0.95
|
|
Discontinued operations
|
—
|
|
|
0.51
|
|
|
0.24
|
|
|||
Net income
|
$
|
1.07
|
|
|
$
|
1.41
|
|
|
$
|
1.20
|
|
(1)
|
The Company has considered the impact of the 2015 Convertible Notes and the restricted shares on diluted earnings per common share. The number of shares of common stock that the 2015 Convertible Notes are convertible into were not included in the computation of diluted net income per common share because the inclusion of those shares would have been anti-dilutive for the year ended
December 31, 2015
.
|
|
For the years ended December 31,
|
||||||||||
|
2017
|
|
2016
|
|
2015
|
||||||
Current
|
$
|
25
|
|
|
$
|
21
|
|
|
$
|
(11
|
)
|
Deferred
|
—
|
|
|
—
|
|
|
—
|
|
|||
Excise tax
|
153
|
|
|
209
|
|
|
—
|
|
|||
Total income tax expense (benefit), including excise tax
|
$
|
178
|
|
|
$
|
230
|
|
|
$
|
(11
|
)
|
•
|
Level 2-Prices are determined using other significant observable inputs. Observable inputs are inputs that other market participants would use in pricing a security. These may include quoted prices for similar securities, interest rates, prepayment speeds, credit risk and others.
|
•
|
Level 3-Prices are determined using significant unobservable inputs. In situations where quoted prices or observable inputs are unavailable (for example, when there is little or no market activity for an investment at the end of the period), unobservable inputs may be used.
|
|
|
|
As of December 31,
|
||||||||||||||
|
|
|
2017
|
|
2016
|
||||||||||||
|
Level in Fair Value Hierarchy
|
|
Carrying Value
|
|
Fair
Value
|
|
Carrying Value
|
|
Fair
Value |
||||||||
Financial assets:
|
|
|
|
|
|
|
|
|
|
||||||||
Loans held for investment
|
3
|
|
$
|
1,726,283
|
|
|
$
|
1,737,286
|
|
|
$
|
1,313,937
|
|
|
$
|
1,322,195
|
|
Financial liabilities:
|
|
|
|
|
|
|
|
|
|
||||||||
Secured funding agreements
|
2
|
|
$
|
957,960
|
|
|
$
|
957,960
|
|
|
$
|
780,713
|
|
|
$
|
780,713
|
|
Secured term loan
|
2
|
|
107,595
|
|
|
110,000
|
|
|
149,878
|
|
|
155,000
|
|
||||
Collateralized loan obligation securitization debt (consolidated VIE)
|
3
|
|
271,211
|
|
|
272,927
|
|
|
—
|
|
|
—
|
|
|
Incurred
|
|
Payable
|
||||||||||||||||
|
For the years ended December 31,
|
|
As of December 31,
|
||||||||||||||||
|
2017
|
|
2016
|
|
2015
|
|
2017
|
|
2016
|
||||||||||
Affiliate Payments
|
|
|
|
|
|
|
|
|
|
||||||||||
Management fees
|
$
|
6,188
|
|
|
$
|
5,608
|
|
|
$
|
5,397
|
|
|
$
|
1,549
|
|
|
$
|
1,549
|
|
Incentive fees
|
381
|
|
|
348
|
|
|
—
|
|
|
—
|
|
|
27
|
|
|||||
General and administrative expenses
|
3,899
|
|
|
3,441
|
|
|
3,426
|
|
|
1,016
|
|
|
1,024
|
|
|||||
Direct costs
|
304
|
|
(1)
|
848
|
|
(2)
|
1,466
|
|
(3)
|
63
|
|
|
99
|
|
|||||
Total
|
$
|
10,772
|
|
|
$
|
10,245
|
|
|
$
|
10,289
|
|
|
$
|
2,628
|
|
|
$
|
2,699
|
|
(1)
|
For the
year ended December 31, 2017
, direct costs incurred are included within general and administrative expenses in the Company’s consolidated statements of operations.
|
(2)
|
For the year ended
December 31, 2016
, direct costs incurred are included within (i) general and administrative expenses of
$486 thousand
and (ii) interest expense of
$362 thousand
in the Company’s consolidated statements of operations.
|
(3)
|
For the year ended
December 31, 2015
, direct costs incurred are included within (i) general and administrative expenses of
$431 thousand
and (ii) interest expense of
$1.0 million
in the Company’s consolidated statements of operations.
|
Date Declared
|
|
Record Date
|
|
Payment Date
|
|
Per Share Amount
|
|
Total Amount
|
||||
November 1, 2017
|
|
December 29, 2017
|
|
January 16, 2018
|
|
$
|
0.27
|
|
|
$
|
7,722
|
|
August 3, 2017
|
|
September 29, 2017
|
|
October 16, 2017
|
|
0.27
|
|
|
7,717
|
|
||
May 2, 2017
|
|
June 30, 2017
|
|
July 17, 2017
|
|
0.27
|
|
|
7,718
|
|
||
March 7, 2017
|
|
March 31, 2017
|
|
April 17, 2017
|
|
0.27
|
|
|
7,690
|
|
||
Total cash dividends declared for the year ended December 31, 2017
|
|
|
|
|
|
$
|
1.08
|
|
|
$
|
30,847
|
|
November 3, 2016
|
|
December 30, 2016
|
|
January 17, 2017
|
|
$
|
0.26
|
|
|
$
|
7,406
|
|
August 4, 2016
|
|
September 30, 2016
|
|
October 17, 2016
|
|
0.26
|
|
|
7,406
|
|
||
May 5, 2016
|
|
June 30, 2016
|
|
July 15, 2016
|
|
0.26
|
|
|
7,413
|
|
||
March 1, 2016
|
|
March 31, 2016
|
|
April 15, 2016
|
|
0.26
|
|
|
7,429
|
|
||
Total cash dividends declared for the year ended December 31, 2016
|
|
|
|
|
|
$
|
1.04
|
|
|
$
|
29,654
|
|
November 5, 2015
|
|
December 31, 2015
|
|
January 19, 2016
|
|
$
|
0.25
|
|
|
$
|
7,152
|
|
July 30, 2015
|
|
September 30, 2015
|
|
October 15, 2015
|
|
0.25
|
|
|
7,152
|
|
||
May 7, 2015
|
|
June 30, 2015
|
|
July 15, 2015
|
|
0.25
|
|
|
7,152
|
|
||
March 5, 2015
|
|
March 31, 2015
|
|
April 15, 2015
|
|
0.25
|
|
|
7,146
|
|
||
Total cash dividends declared for the year ended December 31, 2015
|
|
|
|
|
|
$
|
1.00
|
|
|
$
|
28,602
|
|
Carrying value
|
$
|
37,373
|
|
Maximum exposure to loss
|
$
|
37,679
|
|
|
For the years ended December 31,
|
||||||
|
2016
|
|
2015
|
||||
Mortgage banking revenue:
|
|
|
|
||||
Servicing fees, net
|
$
|
11,081
|
|
|
$
|
16,051
|
|
Gains from mortgage banking activities
|
24,034
|
|
|
27,067
|
|
||
Provision for loss sharing
|
146
|
|
|
1,093
|
|
||
Change in fair value of mortgage servicing rights
|
(6,457
|
)
|
|
(8,798
|
)
|
||
Mortgage banking revenue
|
28,804
|
|
|
35,413
|
|
||
Expenses:
|
|
|
|
||||
Management fees to affiliate
|
446
|
|
|
551
|
|
||
Professional fees
|
718
|
|
|
1,073
|
|
||
Compensation and benefits
|
18,108
|
|
|
20,448
|
|
||
Transaction costs
|
797
|
|
|
—
|
|
||
General and administrative expenses
|
3,049
|
|
|
3,965
|
|
||
General and administrative expenses reimbursed to affiliate
|
622
|
|
|
452
|
|
||
Total expenses
|
23,740
|
|
|
26,489
|
|
||
Income from operations before income taxes
|
5,064
|
|
|
8,924
|
|
||
Income tax expense
|
843
|
|
|
1,939
|
|
||
Net income from operations of discontinued operations, net of income taxes
|
$
|
4,221
|
|
|
$
|
6,985
|
|
|
For the years ended December 31,
|
||||||
|
2016
|
|
2015
|
||||
Current
|
$
|
(1,206
|
)
|
|
$
|
(154
|
)
|
Deferred
|
2,049
|
|
|
2,093
|
|
||
Total income tax expense
|
$
|
843
|
|
|
$
|
1,939
|
|
|
For the years ended December 31,
|
||||
|
2016
|
|
2015
|
||
Federal statutory rate
|
35.0
|
%
|
|
35.0
|
%
|
State income taxes
|
4.4
|
%
|
|
3.6
|
%
|
Federal benefit of state tax deduction
|
(1.5
|
)%
|
|
(1.3
|
)%
|
Effective tax rate
|
37.9
|
%
|
|
37.3
|
%
|
|
For the years ended December 31,
|
||||||
|
2016
|
|
2015
|
||||
Affiliate Payments
|
|
|
|
||||
Management fees (1)
|
$
|
446
|
|
|
$
|
551
|
|
General and administrative expenses (1)
|
622
|
|
|
452
|
|
||
Direct costs (1)
|
68
|
|
|
23
|
|
||
Total
|
$
|
1,136
|
|
|
$
|
1,026
|
|
(1)
|
Management fees incurred are included within management fees to affiliate, general and administrative expenses incurred are included within general and administrative expenses reimbursed to affiliate and direct costs incurred are included within general and administrative expenses for the years ended December 31, 2016 and 2015 in the reconciliation of net income from operations of discontinued operations, net of income taxes.
|
|
For the three month period ended,
|
||||||||||||||
|
March 31
|
|
June 30
|
|
September 30
|
|
December 31
|
||||||||
2017:
|
|
|
|
|
|
|
|
||||||||
Net interest margin
|
$
|
10,339
|
|
|
$
|
10,411
|
|
|
$
|
14,726
|
|
|
$
|
10,872
|
|
Net income attributable to ACRE
|
$
|
6,478
|
|
|
$
|
6,713
|
|
|
$
|
11,058
|
|
|
$
|
6,183
|
|
Net income attributable to common stockholders
|
$
|
6,453
|
|
|
$
|
6,713
|
|
|
$
|
11,058
|
|
|
$
|
6,183
|
|
Net income per common share-Basic
|
$
|
0.23
|
|
|
$
|
0.24
|
|
|
$
|
0.39
|
|
|
$
|
0.22
|
|
Net income per common share-Diluted
|
$
|
0.23
|
|
|
$
|
0.24
|
|
|
$
|
0.39
|
|
|
$
|
0.22
|
|
2016:
|
|
|
|
|
|
|
|
||||||||
Net interest margin
|
$
|
10,225
|
|
|
$
|
10,514
|
|
|
$
|
11,758
|
|
|
$
|
12,610
|
|
Net income attributable to ACRE
|
$
|
6,425
|
|
|
$
|
9,981
|
|
|
$
|
19,741
|
|
|
$
|
8,721
|
|
Net income attributable to common stockholders
|
$
|
5,136
|
|
|
$
|
8,693
|
|
|
$
|
18,442
|
|
|
$
|
8,065
|
|
Net income per common share-Basic
|
$
|
0.18
|
|
|
$
|
0.31
|
|
|
$
|
0.65
|
|
|
$
|
0.28
|
|
Net income per common share-Diluted
|
$
|
0.18
|
|
|
$
|
0.31
|
|
|
$
|
0.65
|
|
|
$
|
0.28
|
|
|
|
|
ARES COMMERCIAL REAL ESTATE CORPORATION
|
|
|
|
|
|
|
Dated:
|
March 1, 2018
|
|
By:
|
/s/ James A. Henderson
|
|
|
|
|
James A. Henderson
|
|
|
|
|
Chief Executive Officer, Chief Investment Officer and President
(Principal Executive Officer)
|
|
|
|
|
|
Dated:
|
March 1, 2018
|
|
By:
|
/s/ Tae-Sik Yoon
|
|
|
|
|
Tae-Sik Yoon
|
|
|
|
|
Chief Financial Officer and Treasurer
(Principal Financial and Accounting Officer)
|
Dated:
|
March 1, 2018
|
|
By:
|
/s/ James A. Henderson
|
|
|
|
|
James A. Henderson
Chief Executive Officer, Director, Chief Investment Officer and
President
(Principal Executive Officer)
|
Dated:
|
March 1, 2018
|
|
By:
|
/s/ Tae-Sik Yoon
|
|
|
|
|
Tae-Sik Yoon
Chief Financial Officer and Treasurer (Principal Financial and Accounting Officer) |
Dated:
|
March 1, 2018
|
|
By:
|
/s/ William S. Benjamin
|
|
|
|
|
William S. Benjamin
Chairman, Director |
Dated:
|
March 1, 2018
|
|
By:
|
/s/ Rand S. April
|
|
|
|
|
Rand S. April
Director
|
Dated:
|
March 1, 2018
|
|
By:
|
/s/ Michael J Arougheti
|
|
|
|
|
Michael J Arougheti
Director
|
Dated:
|
March 1, 2018
|
|
By:
|
/s/ Caroline E. Blakely
|
|
|
|
|
Caroline E. Blakely
Director
|
Dated:
|
March 1, 2018
|
|
By:
|
/s/ William L. Browning
|
|
|
|
|
William L. Browning
Director
|
Dated:
|
March 1, 2018
|
|
By:
|
/s/ James E. Skinner
|
|
|
|
|
James E. Skinner
Director
|
Dated:
|
March 1, 2018
|
|
By:
|
/s/ Kirk A. Sykes
|
|
|
|
|
Kirk A. Sykes
Director
|
By:
|
/s/ Mary Kunka
______________________
Name: Mary Kunka Title: Managing Director |
By:
|
/s/ Jared Randall
______________________
Name: Jared Randall Title: Executive Director |
By:
|
/s/ Mary Kunka
______________________
Name: Mary Kunka Title: Managing Director |
By:
|
/s/ Jared Randall
______________________
Name: Jared Randall Title: Executive Director |
By:
|
/s/ Anthony Capaul
Name: Anthony Capual Title: Assistant Vice President |
By:
|
/s/ Mary Kunka
______________________
Name: Mary Kunka Title: Managing Director |
By:
|
/s/ Jared Randall
______________________
Name: Jared Randall Title: Executive Director |
By:
|
/s/ Mary Kunka
______________________
Name: Mary Kunka Title: Managing Director |
By:
|
/s/ Jared Randall
______________________
Name: Jared Randall Title: Executive Director |
By:
|
/s/ Mary Kunka
______________________
Name: Mary Kunka Title: Managing Director |
By:
|
/s/ Jared Randall
______________________
Name: Jared Randall Title: Executive Director |
By:
|
/s/ Mary Kunka
______________________
Name: Mary Kunka Title: Managing Director |
By:
|
/s/ Jared Randall
______________________
Name: Jared Randall Title: Executive Director |
ARES COMMERCIAL REAL ESTATE CORPORATION
,
a Maryland corporation
By
/s/ John B. Jardine
Name: John B. Jardine
Title: President and Co-Chief Executive
Officer
|
|
|
Name
|
|
Jurisdiction
|
ACRC Holdings LLC
|
|
Delaware
|
ACRC Lender LLC
|
|
Delaware
|
ACRC Lender C LLC
|
|
Delaware
|
ACRC Lender U LLC
|
|
Delaware
|
ACRC Lender U TRS LLC
|
|
Delaware
|
ACRC Lender U Mezz LLC
|
|
Delaware
|
ACRC Lender W LLC
|
|
Delaware
|
ACRC Lender W TRS LLC
|
|
Delaware
|
ACRC Lender B LLC
|
|
Delaware
|
ACRC Lender ML LLC
|
|
Delaware
|
ACRC Mezz Holdings LLC
|
|
Delaware
|
ACRC Warehouse Holdings LLC
|
|
Delaware
|
ACRC Lender US LLC
|
|
Delaware
|
ACRE Commercial Mortgage 2017-FL3 Ltd.
|
|
Cayman
|
ACRE Commercial Mortgage 2017-FL3 LLC
|
|
Delaware
|
ACRC 2017-FL3 TRS LLC
|
|
Delaware
|
(1)
|
Registration Statement (Form S‑3 No. 333-211847) of Ares Commercial Real Estate Corporation, and
|
(2)
|
Registration Statement (Form S‑8 No. 333‑181077) pertaining to the Ares Commercial Real Estate Corporation 2012 Equity Incentive Plan
|
1.
|
I have reviewed this Annual Report on Form 10-K of Ares Commercial Real Estate Corporation;
|
2.
|
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
|
3.
|
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
|
4.
|
The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
|
(a)
|
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
(b)
|
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
(c)
|
Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
|
(d)
|
Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
|
5.
|
The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
|
(a)
|
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
|
(b)
|
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
|
/s/ James A. Henderson
|
|
James A. Henderson
Chief Executive Officer, Chief Investment Officer and President
|
|
1.
|
I have reviewed this Annual Report on Form 10-K of Ares Commercial Real Estate Corporation;
|
2.
|
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
|
3.
|
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
|
4.
|
The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
|
(a)
|
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
(b)
|
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
(c)
|
Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
|
(d)
|
Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
|
5.
|
The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
|
(a)
|
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
|
(b)
|
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
|
/s/ Tae-Sik Yoon
|
|
Tae-Sik Yoon
Chief Financial Officer and Treasurer
|
|
1.
|
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
|
2.
|
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
|
/s/ James A. Henderson
|
|
James A. Henderson
Chief Executive Officer, Chief Investment Officer and President |
|
|
|
/s/ Tae-Sik Yoon
|
|
Tae-Sik Yoon
Chief Financial Officer and Treasurer
|
|